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CHAPTER 1 
GENERAL INTRODUCTION 
2 
With the use of cadaver donors, the number of kidney 
transplantations is growing rapidly. The total number for the 
whole world is estimated at over 100.000. Half of these 
transplantations are performed in Europe. For the Netherlands 
the total number of renal transplantations carried out until 
the end of 1985 amounts to 3.000. Out of these 3.000, nearly 
200 involved children under 15 years of age. 
In the unnatural situation of allogeneic kidney transplan-
I 
tation, where surgeons are attempting to contravene nature by 
inserting foreign proteins into an unwilling host, unusual 
compensatory host mechanisms may take place. One of these 
mechanisms is the development of post-renal transplantation 
hypertension. 
Although a successful renal allograft may cure hyper-
tension, it is now recognized that there is an alarmlingly 
high incidence of hypertension in transplanted patients. In 
this situation hypertension poses diagnostic and therapeutic 
problems in many patients. A variety of factors may be 
responsible for the genesis of blood pressure elevation in the 
post-transplantation period, but an analysis of the importance 
of the various factors is very problematic in humans. 
The aim of the present experiments was to develop a model 
in rats in which post-transplantation hypertension could be 
studied. This model was used to reveal the mechanisms causing 
the hypertension after kidney transplantation in the rat and 
then to find ways to prevent this post-transplantation hyper-
tension in rats. 
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GENERAL INTRODUCTION 
1.2 HISTORICAL OVERVIEW 
A number of problems had to be overcome to allow 
successful transplantation of organs. These problems can be 
divided roughly into two distinct sets. The first set 
comprises the surgical and technical problems of the 
transplantation procedure as such. After half a century of 
continuous research most of these have been solved. 
Conservation of the normal structure and function of the 
grafted organ is now secured by protocols for procurement, 
preparation, 
the living 
storage and surgical relocation of the graft into 
organism. The second set of problems in 
transplantation combines the process of rejection. An 
allograft, 
different 
recipient 
i.e. an organ exchange 
individuals of one species, 
and rejected within one 
between genetically 
is not accepted in the 
to two weeks. With 
xenografts, i.e. organs exchanged between individuals of 
different species, an even more rapid rejection may take 
place. On the other hand, there is the ideal situation of 
isografts where the organ is exchanged between genetically 
identical individuals and survival is indefinite. These two 
sets of problems involving transplantation procedure and 
rejection have been studied extensively in laboratory animals 
and no aspect of medical research has benefitted as much from 
experimental investigation as the field of transplantation 
research. 
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The first experimental success came in the early 1900's 
when Jaboulay (1906) anastomosed kidneys from a pig and a goat 
respectively to an artery and a vein in the arms of two 
patients. After one hour of diuresis the grafts ceased to 
function and were removed. Unger (1910) placed both kidneys 
from a monkey in the groin of a uremic patient. As the 
desiribality of genetic similarity between donor and recipient 
was already recognized at that time, it was no surprise to 
Unger that this transplant did not function. Carrel (1912), 
having perfected the surgical techniques for vascular 
anastomoses, showed that kidney autografts in dogs survived 
for a long time, whereas allografts transplanted by the same 
technique functioned for only a few days. This transplantation 
model was confirmed by the Boston group and on the basis of 
this proven laboratory model, the first successful renal 
transplantation in a human identical twin was carried out 
(Murray et al., 1955; Merril et al., 1956). The recipient 
obtained normal renal function and control of hypertension was 
achieved. 
This first successful human transplantation led to new 
experiments to treat rejection in an effort to extend 
allogeneic transplantation to humans. Two laboratory methods 
of achieving skin allograft survival were adapted to potential 
recipients: acquired immunologic tolerance (Billingham et 
al., 1953) and x-irradiated marrow infused tolerance (Main 
and Prehn, 1955), unfortunately without success. In 1959 
Schwartz and coworkers discovered that 6-mercaptopurine 
poses sed specific immunodepressive properties and this new 
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drug was applied by Calne (1960) and by Zukovski and coworkers 
(1960) to canine renal transplants with good results. Two 
years later, the first 6-mercaptopurine-treated human 
recipient of a cadaver donor kidney survived for over a year 
(Murray et al., 1962). Corticosteroids were then introduced as 
the major immunosuppressive drugs (Goodwin et al., 1962) and 
combined with azathioprine, an analogue of 6-mercaptopurine. 
These drugs remained the basis of immunosuppression for the 
next 20 years. 
Other 
generated 
(Terasaki 
which can 
points of progress in kidney transplantation were 
by the development of tissue typing and matching 
et al., 1966) and methods of kidneys preservation, 
now be maintained for up to three days. For 
practical reasons, kidneys are currently used within 24-36 
hours after harvesting (Belzer et al., 1972). Other, ancillary 
methods of immunosuppression were studied. Localized x-ray 
therapy over the transplant seemed to prolong survival, while 
splenectomy, thymectomy and extracorporeal x-irradiation of 
circulating blood was also tried. The use of anti-
lymphocyte serum and globulin as an immunosuppressive agent 
was developed by Waksman (1961) and Woodruff (1963) and their 
coworkers, while drainage of lymphocytes by thoracic 
cannulation was introduced by Franksson (1964). 
duct 
Finally, in the late 1970's Cyclosporin A (CsA), 
endecapeptide has gained interest as an addition 
a cyclic 
to the 
existing immunosuppressive drugs. Its potent immunosuppressive 
activity has been shown in a number of models, e.g. the 
prolonged survival of kidney, pancreas, skin and heart 
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transplants in rats (Homan et al., 1980; Garvey et al., 1980; 
White et al., 1980; Kostakis et al., 1977). Clinical studies 
have proved that GsA is also immunosuppressive in humans 
(Calne et al., 1981; Starzl et al., 1981). Major side effects 
of CsA in man are its nephrotoxicity and its hepatotoxicity. 
Apart from being reversible, these effects can be contained 
with a reduction in dosage (Calne et al., 1978). Extensive 
clinical trials are carried out to study the properties of CsA 
compared to the conventional immunosuppressive drugs. 
1.3 HYPERTENSION AFTER RENAL TRANSPLANTATION IN MAN 
As mentioned above, human kidney transplantation is still 
in a developmental stage and although the techniques have 
improved considerably with time, optimal immunosuppression is 
not available yet. Consequently, a number of side effects of 
the immunosuppressive drugs have to be accepted. Examples are 
cancer transferred to recipients with allografts (Wilson et 
al.,1968) or the development of de novo cancer in immuno-
suppressed patients (Penn et al., 1979; Calne et al. ,1979). 
Infections with relatively non-pathogenic viruses, fungi and 
protozoa are a direct sequelae of immunosuppression too. Not a 
direct consequence, but strongly related to kidney 
transplantation and immunosuppression is the development of 
aseptic bone necrosis (Griffith et al., 1974), hyperlipidemia 
(Saldanha et al., 1976), cataracts (Wilson et al., 1979), 
growth retardation in children, (McEnergy, 1973) and hyper-
7 
tension. 
The role of renal disease in the pathogenesis of hyper-
tension is well-known and has been studied extensively. For 
example, hypertension is one of the most common complications 
of end-stage renal failure (ESRF). It is present in 80% to 90% 
of patients with irreversible uremia (DelGreco et al., 1975; 
Lazarus et al., 1975), adding to the morbidity and mortality 
of patients who receive maintenance haemodialysis. A 
functioning renal allograft in a hypertensive ESRF patient may 
result in blood pressure control by excreting excess salt and 
water and by suppressing the release of renal pressor 
substance(s) secreted by the recipient's own diseased kidneys. 
Although the anti-hypertensive effects of renal 
transplantation are well documented (Kolff et al., 1964; 
Ducrot et al., 1965), the development or persistence of hyper-
tension have been noted to occur in an alarmingly high 
proportion of patients who have undergone renal 
transplantation. 
1.4 PREVALENCE OF POST-TRANSPLANTATION HYPERTENSION 
Adult recipients 
In the literature there is a wide divergence concerning the 
prevalence of post-transplantation hypertension in adult renal 
recipients as can be seen in TABLE 1. 
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% hypertensive no of patients 
Papadimitriou et al., 1969 
Smellie et al., 1969 
Coles et al., 1972 
Cohen, 1973 
Sampson et al., 1973 
Grunfeld et al., 1975 
Bachy et al., 1976 
Curtis et al.,1976 
Rao et al.,l977 
Jacquot et al., 1978 
Klarskov et al., 1979 
Pollini et al., 1979 
Whelton et al., 1979 
29 
18 
52 
51 
70 
73 
56 
24 
49 
20 
50 
54 
47 
24 
67 
24 
81 
24 
41 
85 
74 
164 
50 
79 
98 
93 
TABLE 1. Prevalence of post-transplantation hypertension 
adults. Criteria for hypertension differ in 
various studies listed above. 
in 
the 
The results of the various studies listed in the table can 
not be compared due to divergence in study populations, timing 
of hypertensive evaluation, immunosuppressive treatment, and 
peri-operative care. Apart from that, the definition of post-
transplantation hypertension is used inconsistently by the 
various authors. Some include all cases that have once been 
hypertensive after transplantation, while others include only 
cases that become or remain hypertensive at a later stable 
phase after transplantation or include only those patients who 
have been given anti-hypertensive treatment. 
The incidence of hypertension tends to vary with time 
following renal transplantation. In the 85 recipients reported 
by Bachy et al.(1976), the proportion of patients with hyper-
tension rose during the first three months, stabilized around 
50% to 60% for up to five years after transplantation and then 
tended to decrease slightly. In this study a third of the 
initially hypertensive patients became normotensive, whereas 
9 
one third of the initially normotensive patients became 
hypertensive. Studies carried out by Rao et al. (1977) also 
showed that a significant number of hypertensive patients 
became normotensive after transplantation. According to some 
authors, the incidence of post-transplantation hypertension 
may vary with the donor source of the transplant. Nerstrom et 
al. (1972) recorded an incidence of 36% in live-related donor 
kidney recipients, whereas Coles et al. (1972) observed an 
incidence of 83% in recipients of cadaver donor kidneys. 
Pollini and coworkers (1979), however, found no difference in 
the incidence of hypertension between cadaver kidney 
recipients and live, related kidney recipients. Whelton et al. 
(1979) found the incidence of hypertension to be 
significantly higher in cadaver graft recipients. This higher 
incidence might also be related to the renal function in 
cadaver recipients, which is generally considered to be much 
poorer than renal function in live, related donor kidney 
recipients. 
Paediatric recipients 
In juvenile kidney recipients, likewise, hypertension is 
a significant problem, but there are some differences in 
comparison with adult recipients. In the immediate post-
operative period, acute hypertension is reported to occur in 
most paediatric transplant recipients, but in few adults. In 
one large series of 137 juvenile recipients the incidence of 
immediate post-transplantation hypertension was noted to be as 
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high as 98% (Ingelfinger, 1981). This high incidence has been 
confirmed by other investigators (Gonzalez et al., 1970; 
Najarian et al., 1971; Fine et al., 1970; Arbus et al., 1980). 
Almost all cases seem to be related to a disproportionate 
positive fluid balance. Once the volume expansion had been 
controlled, the blood pressure often returned to normal values 
(Potter et al., 1970). In the Sophia Children's Hospital 50% 
of the recipients required anti-hypertensive medication during 
the first half year after transplantation, but only 15 % of 
all patients needed anti-hypertensive treatment for more than 
two years (Nauta et al., 1986). 
After the initial post-operative period the percentages of 
post-transplantation hypertension in juvenile patient series 
show as much variation as in the adult series (TABLE 2). 
Williams et al., 1969 
La Plante et al., 1970 
Gonzalez et al., 1970 
Fine et al., 1970 
Najarian et al., 1971 
Lilly et al., 1971 
Cerilli et al., 1972 
Ingelfinger et al., 1975 
Malekzadeh et al., 1975 
Henriksson et al., 1975 
Ingelfinger et al., 1981 
Tejani, 1983 
Breyer, 1985 
% hypertensive 
50 
25 
10 
4 
34 
38 
19 
86 
9 
25 
93 
87 
59 
no of patients 
14 
8 
19 
45 
44 
42 
31 
49 
77 
16 
134 
75 
197 
TABLE 2. Prevalence of post-transplantation hypertension in 
juvenile recipients after the initial post-
operative period. 
A clear difference between adult and juvenile recipients 
is the relative mass of the kidney transplant itself, as most 
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children receive transplants from adult donors. Apart from 
other factors that will be discussed later, the lower cardiac 
output and arterial blood pressure might stimulate large 
kidneys to produce extra renin or, conversely, the large 
kidney might alter the cardiac output and/or the extracellular 
volume causing hypertension. It is also feasible that, due to 
the presence of the large grafted kidney, the perfusion of the 
native kidney(s) decreases, triggering the production of extra 
renin (Linas et al., 1978). To study this hypothesis, 
Caldicott and Ingelfinger (1981) use newborn puppies and 
measured the effects of increasing relative renal mass on 
cardiovascular and renal function. They found that blood 
pressure dropped after a large kidney had been implanted, 
remaining lower than before transplantation. Cardiac output 
did not change significantly in these animals, nor did the 
plasma volume. These experiments suggest that renal mass as 
such does not seem to explain the high frequency of post-
transplantation hypertension in children. 
The 
regulation 
approach 
normally 
1.5 POSSIBLE MECHANISMS OF HYPERTENSION 
IN TRANSPLANTED PATIENTS 
crucial role of the kidney in blood 
has been emphasized by the systems 
used by Guyton and coworkers (1974). The 
controls body fluid volumes while it also 
renin which, by generating angiotensin II, may 
pressure 
analysis 
kidney 
produces 
increase 
peripheral vascular resistance. The kidney may also have an 
anti-hypertensive function through the production of prosta-
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glandins from medullary interstitial cells, while it may well 
secrete other anti-hypertensive substances. Disturbed renal 
function can therefore contribute to a rise in blood pressure 
in a number of ways. The allografted kidney might be disturbed 
in its function by more than one factor. An analysis of the 
relative importance of the various factors involved in post-
transplantation hypertension is complicated. Despite the large 
number of clinical kidney transplantations performed each 
year, every one of these patients presents a singular clinical 
picture. Some of the minor factors contributing to a rise in 
blood pressure deserve a mere mention only, while the major 
ones falling within the context of this thesis, will be 
discussed extensively. 
Possible explanations for the hypertension observed in 
transplanted patients include expansion of the extracellular 
fluid volume (Horvath et al., 1976), extrinsic compression of 
the graft (Cromie et al., 1976), polycythaemia (Swales and 
Evans, 1969), transplantation of a kidney from a hypertensive 
donor (Hume et al., 1966) and even transplantation of a kidney 
from a donor with a family history of hypertension (Bianchi et 
al.,1974; Guidi et al.,1982). Other mechanisms proposed are 
ischaemic damage to the graft during transplantation (Roguska 
et al., 1971), hypercalcaemia (Weidmann et al., 1977), peri-
renal fibrosis (Faarup et al., 1973) or recurrent glomerulo-
nephritis (Cameron and Turner, 1977). 
The major factors involved in the 
transplantation hypertension are thought 
genesis of post-
to include: the 
presence of the recipient's own kidneys, rejection, cortico-
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steroids and renal artery stenosis. In one way or another, 
they are all linked to post-transplantation hypertension by 
the renin-angiotensin system. 
1.6 PLASMA RENIN LEVELS IN POST-TRANSPLANTATION 
HYPERTENSION 
The basal plasma renin levels in hypertensive transplant 
recipients with a good and stable graft function are reported 
to be either normal (Grunfeld et al., 1975; West et al., 1969; 
Sampson et al., 1972) or elevated (Beckerhoff et al., 1974; 
Verniory et al., 1972; McDonald et al., 1974). No correlation 
was found between the basal renin levels and the occurence of 
post-transplantation hypertension. Interpretation of these 
studies is questionable since several non-quantitative, 
variable factors are involved: the use of anti-hypertensive 
drugs and/or diuretics, the renin release from the patients' 
own kidneys and the salt intake by the recipient. In the 
absence of these variable factors, Kornerup (1977) found that 
the basal renin level is normal in hypertensive patients with 
stable graft function. 
Transplanted patients probably differ in the way they 
react to postural changes, i.e. no significant rise in renin 
levels was found after orthostasis (Pedersen and "Kornerup, 
1976). The sympathic denervation of the kidney is a possible 
explanation, while this might also explain the cessation of 
the normal diurnal variation in plasma renin levels of renal 
transplant recipients (Armbruster et al., 1975). On the other 
14 
hand, it seems that the response of the plasma renin to 
changes in sodium intake is normal in patients with post-renal 
transplantation hypertension (Horvath et al., 1976; Keogh et 
al. , 1976). 
1.7 ROLE OF THE RECIPIENT'S OWN DISEASED KIDNEYS IN 
POST-TRANSPLANTATION HYPERTENSION 
Several authors have found that the host kidneys are 
important in the development of hypertension following renal 
transplantation (Coles et al., 1972; Cohen, 1973; Ballet al., 
197 4) . It seems likely that the diseased kidneys contri but·e to 
the development of hypertension by the hypersecretion of 
renin. This is in accordance with the observation of a 
significantly lower plasma concentration of renin in 
transplant recipients subjected to bilateral nephrectomy as 
compared with recipients retaining their own diseased kidneys 
(McHugh et al., 1980). The importance of renin secreted by the 
host kidneys in hypertension after transplantation concurs 
with the observations on the aetiology of hypertension at 
haemodialysis and the response to bilateral nephrectomy 
(Wilkinson et al., 1970). 
There is probably a dual mechanism that causes hyper-
tension in renal transplant recipients secondary to 
overproduction of renin by the own diseased kidneys. The 
hypotensive response to saralasin (a competitive inhibitor of 
angiotensin II) as observed in many hypertensive recipients, 
suggests a direct vasoconstrictor action of angiotensin II. In 
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addition, angiotensin II may contribute to the hypertension by 
causing sodium retention through stimulation of the 
aldosterone 
aldosterone 
secretion (Brown et al., 
excretion was noted to be high 
1979). Urinary 
in hypertensive 
transplant recipients, while there was a significant increase 
in exchangeable sodium in these patients, not explained by 
their dietary sodium intake (McHugh et al., 1980). 
1.8 REJECTION AND HYPERTENSION 
Acute rejection 
Acute rejection may occur within the first week of 
transplantation or, more usually, within the first month, 
while episodes of acute rejection crises may develop many 
months after transplantation. Prominent morphological features 
of the acute rejection process include interstitial cell 
infiltration, interstitial edema, changes in the small blood 
vessels and tubular changes. Glomerular lesions are less 
common. Although hypertension is said to be an inconstant 
marker of acute rejection (Coles et al., 1972) most 
researchers have found elevated plasma renin levels during the 
course of acute rejection (Beckerhoff et al., 1974; Blaufox et 
al., 1966; Gunnels et al., 1966; McDonald et al., 1974; 
Verniory et al., 1972). However, the relationship between 
plasma renin and hypertension in connection with acute 
allograft rejection is unclear. Some studies found a closely 
positive correlation between plasma renin and arterial blood 
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pressure, while others have found a weak correlation or none 
at all. Kornerup (1979) demonstrated that the plasma renin 
pattern was characterized by a moderately elevated plasma 
renin concentration at the start of the acute renal allograft 
reaction, after which the renin concentration normalized in 
the course of the reaction. This drop in plasma renin 
concentration was accompanied by an increase in body weight, 
which suggests that the increased renin release from the renal 
transplant may be involved in the initial phase of the 
development of hypertension in connection with acute renal 
allograft rejection, whereas salt and water retention may be 
responsible at a later stage. 
Chronic rejection 
Chronic rejection of kidney allotransplants becomes 
manifest months or even years after grafting. Morphologically, 
the chronic rejection process is characterized mainly by 
obliterative vascular changes and a wide variety of glomerular 
alterations. Chronic rejection is commonly associated with a 
rise in blood pressure (Ducrot et al., 1965; Bachy et al., 
1976). Roguska and coworkers (1971) and Chrysant and coworkers 
(1974) found elevated plasma renin levels in chronic renal 
allograft rejection. In the latter study, blood pressure was 
closely related .to the plasma renin activity, whereas this 
correlation was weak in the former study. Grunfeld and 
coworkers (1975) found normal renin secretion rates from the 
kidney grafts in post-renal transplantation hypertension in 
17 
connection with chronic renal allograft rejection. 
The different outcomes of these studies are not surprising 
considering the many factors which may effect the renin 
system. Increased renin release from the recipients' own 
kidneys was not excluded as a possible reason for the 
elevated plasma renin levels. Furthermore, differences in the 
character of the allograft rejection reaction must be expected 
to depress renal function and to affect the transplant's 
juxtaglomerular apparatus in different ways, contributing to 
either stimulated or depressed renin release. 
1.9 TRANSPLANT RENAL ARTERY STENOSIS AND HYPERTENSION 
Renal artery stenosis is a well-known complication of 
renal transplantation (Vidne et al., 1976) 
contribute to post-transplantation hypertension. 
which may 
The quoted 
incidence of transplant renal artery stenosis varies from 1% 
to 10%. Bachy and coworkers (1976) studied 14 arteriograms in 
11 out of 89 recipients and found a stenosis in 5 patients. 
Rao and coworkers (1978) noticed stenosis in 11 out of 15 
patients who underwent angiography because of severe hyper-
tension, an incidence of 4% of all allograft recipients. In 
children a similar incidence of 4% has been reported by the 
Boston group (Ingelfinger et al. 1981). 
These figures, however, underestimate the actual incidence 
of renal artery stenosis in transplant recipients. Renal 
angiography is usually performed only in patients with severe 
hypertension or an unexplained deterioration of graft 
18 
function. Lacombe (1975) found that in 100 consecutive 
transplant patients routine arteriograms demonstrated stenosis 
in 25% of the cases. This 25% incidence in the transplant 
population was confirmed by Grunfeld and coworkers (1975). 
That group also reported that the frequency of graft artery 
stenosis rose to 33% in transplant recipients with 
hypertension. In another study, Bennett and coworkers (1974) 
found narrowing of the graft artery in 31% of the recipients 
with hypertension. 
The success of reconstructive surgery in controlling 
hypertension varies from-33% to 100% in the different studies 
(Lacombe, 1975; Grunfeld et al., 1975; Goldman et al., 1975; 
Nerstrom et al., 1972). Procedures aimed at correcting the 
hypoperfusion may lead to severe complications such as loss 
of the graft and death of the patient, while recurrence of the 
stenosis and hypertension was very common in some studies (Lee 
et al., 1972; Dayle et al., 1975). An association between 
artery stenosis and hypertension does not always appear to be 
causal. In a large series of 367 patients who underwent 
angiography, 22 (6%) were found to have stenosis, but only 13 
of them were hypertensive (Henriksson et al., 1975). Not even 
a correlation between plasma renin and hypertension in 
transplanted patients with graft artery stenosis could be 
established. Under standardized research conditions, Kornerup 
and coworkers (1977) demonstrated elevated basal values of the 
plasma renin concentration in only 3 of 9 bilaterally 
nephrectomized 
hypertension and 
recipients with post-transplantation 
stenosis of the renal graft artery. No 
19 
differences were found in plasma renin concentration, 
comparing hypertensive patients with transplant artery 
stenosis and normotensive recipients examined on either low or 
high sodium intake. These results are in agreement with 
al., 1974; studies carried out by other groups (Bennett et 
Grunfeld et al., 1975; Henriksson et al., 1976). 
the renin system's activity may be elevated but is 
In summary, 
generally 
normal in 
hypertension 
recipients with post-renal transplantation 
and stenosis of the renal graft artery. 
1.10 CORTICOSTEROIDS AND HYPERTENSION 
From studies of 
erythematosus, rheumatoid 
patients with 
arthritis and 
systemic 
other 
lupus 
chronic 
diseases, it is known that administration of glucocorticoids 
is implicated in the development of hypertension (Bulkley and 
Roberts, 1975). Several authors believe that corticosteroids 
are important in the genesis of post-transplantation 
hypertension (Lacombe, 1975; Starzl et al., 1964). Popovtzer 
and coworkers (1973) found a correlation between diastolic 
blood pressure and the dose of prednisone in a group of renal 
recipients. Other authors, however, were unable to demonstrate 
an association between the administration of corticosteroids 
and post-transplantation hypertension (Bachy et al., 1975; 
Coles et al., 1972; Cohen, 1973). In yet another report of a 
series of hypertensive renal transplant recipients, a normal 
blood pressure was noted to prevail as time elapsed and the 
dose of corticosteroids was reduced (Starzl et al., 1964). 
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Furthermore, Curtis and coworkers (1976) noted an incidence of 
hypertension in only 24% of their transplant population 
treated with alternate-day steroid therapy, contrasting with a 
much higher frequency reported by other centers where patients 
received steroids daily. 
after conversion to 
Sampson and Albert (1973) found that 
alternate-day therapy, all renal 
transplant recipients had a fall in blood pressure and those 
previously requiring anti-hypertensive drugs no longer needed 
them. All these studies implied a possible cause and effect 
relationship between the level of blood pressure and the dose 
of steroids. 
Several mechanisms have been proposed to explain the 
hypertensive effects of steroids. In a group of renal 
allograft recipients an elevated aldosterone secretion was 
found in spite of normal plasma activity (Sampson et al., 
1972). Resolution of hypertension was observed with conversion 
of daily prednisone therapy to alternate-day methyl-
prednisolone therapy and this was associated with a 
significant reduction in the aldosterone secretion rate 
(Sampson and Albert, 1973). Sampson and coworkers (1973) also 
reported a prompt decrease in blood pressure when the hyper-
tensive recipients were treated with the aldosterone 
antagonist spironolactone. The conclusion of this study was 
that prednisone was metabolized to aldosterone, causing a 
syndrome of 
development of 
mineralocorticoid excess and subsequent 
hypertension. Experimental animal studies 
subsequently suggested that the redistribution of body fluid 
volumes (Haack et al., 1977) and increased activity of the 
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renin-angiotensin system is due to an increase of renin 
substrate production (Krakoff et al., 1975). The latter study 
also indicated that glucocorticoids are able to potentiate the 
vasoconstrictor action of angiotensin II. Finally, 
mineralocorticoids are known to cause sodium retention (Gomez-
Sanchez et al., 1970; Marcus et al., 1952). 
1.11 THE PRESENT STUDY 
In the present study rats were chosen as experimental 
animals for a number of reasons. Nowadays, the rat is the most 
generally used animal in hypertension and transplantation 
research. The use of inbred rat strains enables large series 
of allogeneic transplantations in which rejection is a 
reproducible phenomenon, while isogeneic kidney 
transplantation may serve as control since rejection will not 
occur. Moreover, rats are relatively cheap and easy to 
maintain. A disadvantage of renal transplantation in the rat 
is the difficulty of the operation, causing a number of 
technical failures. 
Many reports have demonstrated the usefulness of rats for 
renal transplantation studies. The chronic and acute r~jection 
patterns after transplantation between two inbred rat strains 
were studied extensively (Guttmann et al., 1967; White et al., 
1969; Ippolito et al., 1972). Immunosuppressive properties of 
different agents were studied in allogeneic kidney transplan-
tation (Tinbergen, 1968; Guttmann et al., 1969). The role of 
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the kidney in the pathogenesis of hypertension was studied 
with the aid of isogeneic kidney cross-transplantation between 
spontaneously hypertensive rats and their 
counterparts (Bianchi et al., 1974; Dahl and 
normotensive 
Heine, 1975; 
Kawabe et al., 1969). The effects of aging upon functional and 
cellular aspects of kidney transplants have also been studied 
in the rat (van Bezooijen et al., 1974). Finally, a method has 
been developed to determine the glomerular filtration rate in 
rats, based on a report by Layzell and Miller (1975). This 
method allows for repeated measurements in the same animal 
(Provoost et al., 1983). Assessment of the function of the 
grafted kidney in experimental 
received little attention to date, 
ideal opportunity to study the 
transplantation in rats. 
renal transplantation has 
this method provided an 
functional changes after 
As mentioned before, the pathogenesis of post-
transplantation hypertension can be divided into those related 
to the donor, those associated with the recipient in 
combination with the transplantation procedure itself and 
those uniquely related to the post-transplantation course. The 
complex interrelationships of these factors make it very 
difficult to analyze precisely the etiology of hypertension 
after renal transplantation. We chose to start with an 
isogeneic transplantation model in which rejection and the use 
of immunosuppressive drugs is not present. In this rat model 
we would be 
transplantation 
able to investigate the effects of the 
procedure itself. After that investigation a 
new feature would be included in the transplantation model, 
23 
namely the effect of rejection by transplanting a renal 
allograft from an antigenically disparate source. The rat 
donor rat recipient combination used by us allows for 
prolonged allograft survival with the aid of donor strain 
blood transfusions (Marquet, 1978). Consequently, at this 
stage the use of other immunomodulating drugs could still be 
avoided. To mimic the clinical situation, the next step was 
the introduction of different immunosuppressive drugs and the 
evaluation of the effects of these drugs on the development of 
post-transplantation hypertension. Finally, we tried to define 
the role of sodium in the genesis of post-transplantation 
hypertension in the original model. This involved the use of a 
low-sodium diet, while in a separate metabolic experiment the 
renal allograft handling of electrolytes and water would be 
examined in more detail. 
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CHAPTER 2 
THE GLOMERULAR FILTRATION RATE OF ISOGENEICALLY 
TRANSPLANTED RAT KIDNEYS 
This chapter has been published in 
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The glomerular filtration rate of isogeneically 
transplanted rat kidneys 
ABRAHAM P. PROVOOST, MAluNUS H. DE KEUZER, WIL J. KORT, ERIK D. WOLFF, 
and JAN C. MoLENAAR 
Departments of Pediatric Surgery and Nephrology and Laboratory for Surgery, Erasmus University School of Medicine, 
Rotterdam, The Netherlands 
The glomerular filtration rate of isogeneically transplanted rat kidneys. 
The glomerular filtration rate (GFR) was determined in rats with an 
isogeneic kidney transplant and compared with that of unilaterally 
nephrectomized rats. Experiments were canied out in adult rats, 3 
months of age, weighing approximately 300 g, as well as in juvenile rats, 
6 to 8 weeks of age, weighing approximately 170 g. All donor kidneys 
were taken from adult rats. The GFR was measured regularly, using a 
chromium 51-EDTA clearance technique which pennitted repeated 
measurements to be taken in the same animals, during a 15-week 
followup period. After unilateral nephrectomy the GFR per 100 g body 
weight (BW) increased compared with that of a single normal kidney. 
Adult transplant recipients had a GFR per 100 g BW of about 80% of 
that of unilaterally nephrectomized rats. There was no statistical 
difference in the GFR when comparing adult recipients of either a 
normal or a hyperfunctional kidney. When isografts were transplanted 
to juvenile recipients, there was an initial decrease in the absolute GFR 
compared with the donor value in the case of a normal adult donor 
kidney. This decrease was even more pronounced when a hypetfunc-
tioning kidney was transplanted to a juvenile recipient. However, when 
related to BWthe GFR was, as in the adult recipients, about 80%ofthat 
of unilaterally nephrectomized juvenile rats. During the followup period 
the systolic blood pressure was measured regularly by tail plethysmog-
raphy, in order to detect any blood pressure elevations, which are a 
frequent complication in adult and pediatric human renal transplanta-
tion. However, no hypertension was observed after isogeneic kidney 
transplantation in the various groups. These results show that the GFR 
of isogeneically transplanted rat kidneys amounts to about 80% of the 
maximally attainable level. Isogeneic transplantation of an adult kidney 
to a juvenile recipient results in a rapid adaptation of the GFR to the 
smaller size of the body and does not cause an increase in blood 
pressure. 
Debit de filtration glomtrulaire des reins de rat en situation de 
transplantation isogenique. Le debit de filtration glomerulaire a ete 
determine chez des rats ayant un transplant renal isogenique et compare 
a celui de rats ayant eu une nephrectomie unilat6rale. Les experiences 
ont ete conduites chez des rats adultes, ages de trois mois, dont le poids 
corpore! etait de 300 g et chez des rats jeunes, ages de six a huit 
semaines. dent le poids corpore! etait de 170 g. Tous les transplants 
provenaient de rats adultes. Le debit de filtration glomerulaire a ete 
mesure a intervalles reguliers pendant une p6riode de 15 semaines au 
moyen de Ia clearance de 51Cr-EDTA, cette technique permet des 
mesures repetees chez le meme animal. Apres nephrectomie unilater~ 
ale, le debit de filtration glomerulaire par 100 g de poids corpore! 
augmente par comparaison avec c'!lui d'un rein unique. Les receveurs 
adultes ont un debit de filtration glomerulaire par 100 g d'environ 80% 
celui des rats ayant subi une nephrectomie unilaterale. II n 'y a pas de 
difference statistiquement significative entre les debits de filtration 
glom6rulaire des adultes ayant re~u un rein normal ou un rein hyper~ 
fonctionnant. Quand les isogreffes ont 6te transplant6es a des receveurs 
jeunes, il a ete observe une diminution initiate du debit de filtration 
glom6rulaire absolue par comparaison avec la valeur obtenue chez le 
donneur dans le cas d'un donneur adulte normal. Cette diminution est 
encore plus importante quand un rein hypexfonctionnant est transplante 
a un receveur jeune. Cependant, le d6bit de filtration glom6rulaire 
rapport¢ au poids corpore! est, comme chez les receveurs adultes, 
d'environ 80% celui des rats jeunes ayant subi une nephrectomie 
unilaterale. Durant Ia p6riode d'observation la pression sanguine systo-
lique a ete mesuree r6gulierement par plethysmographie de Ia queue, de 
fac;on a d6tecter une elevation de la pression arterielle, ce qui est une 
complication frequente de la transplantation humaine aussi bien chez 
l'adulte que chez I' enfant. Cependant. il n 'a pas ete observe d'hyperten-
sion art6rielle apres Ia transplantation r6nale isogenique dans les 
diff6rents groupes. Ces r6sultats montrent que le d6bit de filtration 
glom6rulaire des reins de rat transplant6s de fac;on isogenique est 
d'environ 80% du niveau maximum qui peut ~tre atteint. La transplan-
tation isog6nique d'un rein adulte a un receveur jeune a pour conse-
quence une adaptation rapide du debit de filtration glomerulaire a Ia 
plus petite taille corporelle. La transplantation r6nale isogenique ne 
d6tennine pas d'augmentation de la pression sanguine. 
Kidney transplantation in rats is one of the most frequently 
used models in organ transplantation research. Basic informa-
tion concerning rejection and immunosuppression has been 
gathered. However, the function of the transplanted kidney has 
received much less attention in renal research. Apart from a 
number of recent studies in the early post-transplantation 
period [1-3], no measurements of the glomerular filtration rate 
(GFR) of transplanted kidneys have been reported. Followup 
studies of rat kidney transplant recipients, exceeding one week, 
mainly used plasma levels of urea and/or creatinine as indica-
tors of renal function [4-7]. These parameters are not very well 
suited to determine a relatively small impairment of the GFR. 
Recently, a method was developed to measure the GFR in 
rats, which permitted repeated measurements in the same 
animals [8]. This method was used to follow the changes in the 
GFR after isogeneic kidney transplantation of adult donor 
kidneys to adult and juvenile recipient rats. Isogeneic kidney 
transplantation circumvents kidney damage caused by rejec· 
tion. Consequently, this model provides information about the 
degree of damage caused by the transplantation procedure. 
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Juvenile recipients were used, because in pediatric renal trans-
plantation most donor kidneys stem from adults. In juvenile 
recipients it is important to know what level of renal function is 
to be expected. It remains to be seen whether or not the adult 
kidney continues to function as it does in the donor body or 
adapts to the immature size of the juvenile recipient. 
The GFR of transplanted kidneys was compared with that of 
kidneys remaining after unilateral nephrectomy, that is, the 
maximally attainable level of a single intact kidney. Because it 
may be possible that the compensatory response is reduced in a 
transplanted kidney, compensatory hyperfunctioning kidneys 
were also used as donor kidneys. 
Hypertension has been noted to be a frequent complication of 
human renal transplantation in adults [9, 10] as well as in 
children [11]. The occurrence of a rise in blood pressure has 
been studied after kidney transplantation between rat strains 
with various types of genetically mediated hypertension [12, 
13]. However, no studies have been reported on the effects of 
kidney transplantation in normotensive rats, especially from 
adult donors to juvenile recipients, upon the post-transplant 
blood pressure. We therefore measured the systolic blood 
pressure regularly up to the end of the followup period. 
Methods 
The experiments were performed with male rats of a highly 
inbred (continuous brother-sister mating) Wistar strain (WAG/ 
Ro) bred at the Central Anitnal Breeding Center of the Erasmus 
University, Rotterdam. This strain was obtained originally from 
TNO (Rijswijk, The Netherlands) as the WAG!Rij strain. Ge-
netic homogeneity of this particular strain has been confirmed 
by the permanent survival of intrastrain skin-, heart-, and 
kidney grafts [14, 15]. 
The anitnals had food (rat chow AM IT, Hope Farms, 
containing 90 mEq Na/kg) and water (containing 3 mEq Nail) 
available ad libitum. The adult rats used were about 13 to 15 
weeks old with a body weight (BW) of275 to 325 g. The juvenile 
rats were 6 to 8 weeks old with a BW of 135 to 200 gat the time 
of transplantation. 
Surgery 
The microsurgical technique as described by Fisher and Lee 
[16] was used for heterotopic renal transplantation, with a slight 
modification of the ureter-bladder anastomosis. Only right 
donor kidneys were used for transplantation. 
Donor kidney preparation. Under ether anesthesia the abdo-
men of the donor rat was opened; the right kidney together with 
its renal artery and vein was mobilized. The ureter was freed 
and transected near the bladder. After i. v. injection of heparin 
(50 I. U.), the animal was bled to death. and the kidney was 
removed from the body in such a way that elliptical cuffs of the 
aorta and the vena cava were left at the end of the renal vessels. 
The kidney was then kept at 4° C in a 0.9% sodium chloride 
solution. 
Transplantation. Under ether anesthesia the abdomen of the 
recipient rat was opened and the aorta and the vena cava were 
clamped below the renal vessels with a Satinsky-like curved 
clamp. Small openings were made in the clamped part of the 
vessels to which the cuffs of the transplant vessels were 
anastomosed. End-to-side anastomoses were made by continu-
ous suturing using 7-0 silk in the adult and 8-0 nylon in juvenile 
recipients. After the completion of the suturing, recirculation 
was effected by removing the clamp. Bleeding was controlled 
by the gentle pressure of a cotton wool roll. 
The total ischemic time varied between 30 and 40 min and did 
not differ in regard to transplantation of either adult or juvenile 
recipients. 
After restoring the blood supply to the transplanted kidney, 
the ureter-bladder anastomosis was made. A small opening was 
made in the bladder fundus. The ureter tip was then drawn into 
the bladder through the opening. After securing the ureter to the 
low dorsal part of the bladder wall with one suture, the bladder 
opening was closed with a short continuous silk suture. 
Bilateral nephrectomy of the recipient's own kidneys was 
performed under ether anesthesia with an abdominal approach, 
one week after the transplantation. 
Unilateral nephrectomy. Because we transplanted only right 
kidneys, we removed the left kidney of the control rats. This 
nephrectomy was carried out under ether anesthesia through a 
midline incision in adult and juvenile rats. Thus the GFR of the 
transplanted right kidneys was then compared with the maxi-
mally attainable GFR, that is. that of hyperfunctioning single 
right kidneys in the control group. 
Glomerular filtration rate 
The GFR was measured under pentobarbital anesthesia (60 
mg/kg i.p.), using an i.v. injection of chromium 51-EDTA and a 
single timed (60 min) blood sample [8, 17]. The GFR (clearance 
of chromium 51-EDTA) is then calculated from the formula: 
GFR = ~ ·In P.,!P, 
t 
where GFR = clearance (ml/min), V = distribution volume of 
chromium 51-EDTA (ml). P0 , P, = plasma concentration of 
chromium 51-EDTA at time zero and t min (cpm/ml). P, is 
derived from the plasma sample at t (60) min. Po is calculated 
from P 0 = I/V, where I is the injected amount of chromium 51-
EDTA (cpm) and V the distribution volume. 
From the clearance formula it is obvious that V plays an 
itnportant role in the calculation of the GFR. The V is related to 
the BW of the rat, V = v' · BW. In adult rats v' was reported to 
be 0.198 ± 0.012 (mean± so, N = 5) [17]. In juvenile rats. with 
a mean BW of 172 g, V was 0.225 ± 0.011 (mean ± so. N = 8). 
It may well be that v' changes in the different experimental 
situations. The effect of a change in the actual v' upon the 
calculated GFR is variable. When we substitute V = v' · BW 
and t = 60, and relate the GFR to 100 g BW, the clearance 
formula becomes: 
GFR per 100 g BW = 1.667 v' · 1n (I + BW · P,) · (I + v') 
Thus. v' is present as an augmenting as well as a depressing 
factor in the formula. The overall effect of a change in the actual 
v' from the one used to calculate the GFR (0.20 in the case of 
adult rats) is dependent upon the value of!+ (BW · PJ, that is, 
the actual GFR per 100 g BW. 
Effects of changes in v' from 0.20 upon the calculated GFR 
per 100 g BW are depicted in Figure 1. In the normal GFR range 
(0.6 to 0.8 ml/min per 100 g BW) changes of up to 10% in the 
GFR will be the result of an increase in the actual v' with about 
20% (0.20 to 0.24) or a decrease of about 15% (0.20 to 0.17). In 
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Fig. 1. The effect of a change in the actual value of v' upon the 
calculated GFR per 100 g BW in rats. The ~bscissa shows the GFR per 
100 g BW calculated with v' = 0.20. The ordinate gives the GFRper 100 
g BW calculated for various values of v'. as indicated on the righthand 
side of the figure and represented by the various lines. The shaded area 
is the GFR per 100 g BW calculated for v' = 0.20 plus or minus 10%. C 
is the GFR range in two kidney control rats. NX is the GFR range in 
rats with a bypexfunctioning single kidney. TX is the GFR range in rats 
with isogeneically transplanted kidneys. 
the GFR range found in rats with a single compensatory 
hyperfunctioning kidney (0.45 to 0.6 mVmin per 100 g BW) the 
effect of a change in the actual v' is much less, while it is almost 
absent in the GFR range found in rats with an isogeneically 
transplanted kidney (0.3 to 0.5 mVmin per 100 g BW). Large 
relative deflections will be found in the very low GFR range. 
although absolute differences from the calculated GFR will 
remain small. For example, a value of 0.10 mVmin per 100 g 
BW, calculated with v' is 0.20, would be 0.05 mVmin per 100 g 
BW if the actual value of v' were 0.24. 
From these considerations we concluded, that although v' 
may be different in the various experimental models, the effects 
upon the calculated GFR will remain relatively small and do not 
outweigh the advantages of this method provided by the facility 
and the possibility of repeated use in the same animals. 
Systolic blood pressure 
The systolic blood pressure was obtained from trained, 
conscious but restrained animals by the tail cuff method, using a 
sphygmomanometer (Narco Bio-systems, Houston, Texas). 
Blood pressure recordings were taken in a quiet surrounding, 
twice a week throughout the followup period. 
Experimental protocol 
Six groups of rats undergoing different treatments were 
studied. Group 1 consisted of adult rats that underwent a 
unilateral nephrectomy. Group 2 consisted of adult rats that 
received a normal kidney transplant from a two-kidney adult 
donor rat. In group 3 adult rats received a hyperfunctioning 
kidney transplant from an adult donor rat that had been 
mtilaterally nephrectomized three weeks earlier. Group 4 con-
tained juvenile rats that underwent a unilateral nephrectomy. 
Group 5 contained juvenile rats that received a normal kidney 
from a two-kidney adult donor rat and group 6 contained 
juvenile rats that received a hyperfunctioning kidney from an 
adult donor rat. 
The initial number of successful operations as well as the 
number of animals completing the study are given in Table !. 
Most of the losses were due to complications during the 
repeated GFR measurements. In donor rats the GFR was 
measured about one week before transplantation of the kidney. 
The GFR of the control groups 1 and 4 was first measured one 
week before unilateral nephrectomy. In the followup period all 
rats had theirGFR determined!, 3, 9, and 15weeks after either 
bilateral removal of the recipient's own kidneys or after unilat-
eral nephrectomy in control rats. 
Statistics 
Longitudinal differences within each group of rats between 
the GFR values before and after unilateral nephrectomy or 
between the donor GFR and the GFR after kidney transplanta-
tion were compared using paired Student's t tests. 
Differences in means among the groups in either the adult rat 
experiments (groups 1, 2, 3) or the juvenile rat experiments 
(groups 4, 5, 6) were compared by a one-way analysis of the 
variance. In case of significant differences among these three 
groups (P < 0.05), the Newman-Keuls test was used to find 
which pairs of means were different [18]. 
Results 
Body weight 
Changes in the BW of the rats after the various treatments are 
given in Table 2. In adult rats kidney transplantation causes a 
decrease in BW. A 5 to 12% drop in BW was noted one week 
after the removal of the recipients own kidneys. From then on 
BW increased again. At the end of the 15-week followup period 
the BW of rats with a kidney transplant was about 5% less than 
that of unilaterally nephrectomized adult control rats. 
In juvenile rats there was an arrest in growth until two weeks 
after kidney transplantation, while subsequently there was a 
period of a rapid increase in BW. At the end of the followup 
period the BW of rats with a kidney transplant was about 5 to 
10% less than that of unilaterally nephrectomized juvenile 
control rats. 
Glomerular filtration rate 
The changes in the GFR and in the GFR per 100 g BW noted 
in adult rats after unilateral nephrectomy or after the transplan-
tation of either a normal or a hyperfunctioning kidney are 
depicted in Figure 2 (a and b). 
In unilaterally nephrectomized rats (A NX) there was a rapid 
increase in the GFR, compared with 50% of the prenephrec-
tomy level, during the first week after nephrectomy. The GFR 
per 100 g BW at the end of the first week amounted to 131% of 
the single kidney level. Subsequently, there was a further slight 
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Table 1. Experimental treatments and numbers of rats starting the study (N) and completing (n) the 15-week followup period 
Group Treatment Code n!N 
Unilateral nephrectomy in adult rats I 
2 
3 
4 
5 
6 
Transplantation of a normal adult kidney to an adult recipient 
Transplantation of a hyperfunctioning kidney to an adult recipient 
Unilateral nephrectomy in juvenile rats 
ANX 
ATXN 
ATXH 
YNX 
YTXN 
YTXH 
101!2 
8112 
6110 
12112 
13116 
7110 
Transplantation of a normal adult kidney to a juvenile recipient 
Transplantation of a hyperfunctioning kidney to a juvenile recipient 
Table 2. Changes in body wt of adult or juvenile rats following unilateral nephrectomy or isogeneic kidney transplantation" 
Weeks post NX 
Codeb PRE TX NX 15 N 
ANX 316 ± 3 316 ± 4 306 ± 3 313 ± 3 344 ± 356 ± (10) 
ATXN 307 ± go 315 ± 6 277 ± 5 293 ± 6 332 ± 344 ± 8 (8) 
ATXH 306 ± 7' 305 ± 6 288 ± 7 304± 9 322 ± 338 ± 10 (6) 
YNX 162 ± 4 171 ± 5 188 ± 6 217 ± 6 280 ± 313 ± 4 (12) 
YTXN 306 ± 6' 181 ± 6 178 ± 5 208 ± 6 261 ± 8 301 ± 7 (13) 
YTXH 310 ±Ill' 161 ± 6 167 ± 6 209 ± 8 257 ± 12 284 ± 12 (7) 
" Data given are mean values ± SEM; the number of rats (N) is given in parentheses. 
b For explanation of abbreviations see Table 1. 
c Body wt of donor rat is given. 
Abbreviations used are defined: PRE, data obtained one week before transplantation or unilateral nephrectomy; TX, data obtained at the day of 
transplantation; NX, data obtained at the day of unilateral nephrectomy in A NX and Y NX, and at the day of bilateral nephrectomy of the 
recipients own kidneys in the transplant groups. being one week after transplantation. 
increase. The GFR per 100 g BW was at a stable level of about 
145% of the prenephrectomy value from 3 to 15 weeks. 
After the transplantation of a normal kidney to adult recipient 
rats, the GFR as well as the GFR per 100 g BW was not 
significantly different from 50% of the donor value one week 
after the removal of the recipients' own kidneys. However, 
from three weeks onward both values were significantly higher 
than the donor values. The average GFR per 100 g BW of adult 
recipient rats (A TXN) who received the transplantation of 
normal adult kidneys, between 3 and 15 weeks. amounted to 
78% of that of A NX control rats. 
After the transplantation of a hyperfunctioning kidney to 
adult rats, a significant drop in the GFR and in the GFR per 100 
g BW, compared with the donor level, was observed at one and 
three weeks after the removal of the recipient's own kidneys. 
Although the GFR remained lower than the donor value, this 
difference was no longer significant after 9 and 15 weeks. 
Between 3 and 15 weeks the average GFRper 100 g BW of adult 
recipient rats (A TXH) transplanted with hyperfunctioning 
kidneys was 80% of that of A NX control rats. 
As a consequence of the divergent changes after the trans-
plantation of either a normal or a hyperfunctioning kidney, 
analysis of variance showed no significant differences between 
the GFR and the GFR per 100 g BW of A TXN and that of A 
TXH rats. Both transplant groups, however, had a GFR and a 
GFR per 100 g BW that was significantly lower than that of A 
NXrats (GFR:P < 0.01 for both A TXNandA TXHatweeks 1, 
3, 9, and 15; GFR per 100 g BW: P < 0.01 for A TXN at weeks 3, 
9, and 15 and for A TXH at weeks 1, 3, and 15, P < 0.05 for A 
TXN at week 1, and for A TXH at week 9). 
From the combined data of both adult transplant groups, it 
can be deduced that the GFR of isogeneically transplanted 
kidneys was about 80% of the maximally attainable level. 
The changes in the GFR and the GFR per 100 g BW noted in 
juvenile rats after unilateral nephrectomy or after the transplan-
tation of either a normal or a hyperfunctioning adult kidney are 
depicted in Figure 3 (a and b). 
After the transplantation of a normal adult kidney to juvenile 
recipient rats, there was an initial decrease in the GFR to about 
70% of the pretransplant donor GFR. The level of the GFR 
increased again as BW of the recipient increased. At the end of 
the 15-week followup period, when the recipient's BW was 
about the same as that of the adult donor rats, the GFR was 
significantly increased to about 125% of the GFR of the donor 
kidney. Despite the initial decrease in the GFR after the 
transplantation, the GFR per 100 g BW of the juvenile recipient 
rats (Y TXN) transplanted with normal adult kidneys was 
significantly higher than 50% of that of the donor rats and 
remained higher throughout the followup period. 
After the transplantation of a hyperfunctioning adult kidney 
to a juvenile recipient. the decrease in the GFR was much more 
pronounced than after the transplantation of a normal adult 
kidney. The GFR was, one week after the removal of the 
recipient's own kidneys, about 50% of the donor value. The 
GFR increased again as the BW of the recipient increased but 
remained significantly lower than the donor value throughout 
the followup period. 
The GFR per 100 g BW of the juvenile recipients was not 
significantly different from 50% of that of the donor rats during 
the followup period. As in adult recipients analysis of the 
variance did not show any significant differences in either the 
GFR or the GFR per 100 g BW when comparing the recipients 
of a normal or a hyperfunctioning adult kidney. Both transplant 
groups had a GFR and a GFR per 100 g BW that were, in 
general, significantly lower than those of juvenile rats unilater-
ally nephrectomized (Y NX) (GFR: P < 0.01 for Y TXN at 
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Fig. 2. A The glomerular filtration rate (GFR) andB the GFRper 100 g 
body wt of normal and hypeifunctioning adult kidneys transplanted 
isogeneically to adult rat recipients compared with that of unilaterally 
nephrectomized rats. Symbols used are: .t.--.t. A NX (10); 0--0 A 
TXN (8); e-e A TXH (6). The number in parentheses is the number 
of rats in that particular group. For group abbreviations see Table 1; 
PRE control and N donor values represent 50% of the actual measured 
GFR in order to obtain the GFR of a single kidney; TX, the week of 
transplantation; NX, the week of either unilateral nephrectomy of the 
controls or bilateral nephrectomy of the transplant recipient's own 
kidneys. Letter symbols are defined: a, P < 0.05; b, P < O.oJ; c, P < 
0.005; d, P < 0.001 compared with the PRE value (paired t test). (Data 
given are means ± sEM.) 
weeks 1, 3, 9, and 15 and for juvenile recipients transplanted 
with hyperfunctioningkidneys (YTX,V at weeks l, and 15, P <' 
0.05forYTXH at weeks 3, and9; GFRper 100gBW: P < 0.01 
for Y TXN at weeks 1, 3, and 9, and for Y TXH at weeks 1, and 
15, P < 0.05 for Y TXN at week 15 and for Y TXH at week 3). 
By combining Y TXN and Y TXH, it can be stated that the 
GFR per I 00 g B W of isogeneically transplanted adult kidneys 
to juvenile recipients amounted to about 75 to 80% of the GFR 
of juvenile unilaterally nephrectomized rats. 
Systolic blood pressure 
No major changes were observed in the normotensive systol-
ic blood pressure level after the rats received either a unilateral 
nephrectomy or an isogeneic kidney transplantation. For com-
parison the averages are given for 10 to 12 successive blood 
pressure recordings obtained between 6 and 12 weeks after 
nephrectomy (Table 3). 
Discussion 
The GFR of isogeneicaJJy transplanted adult rat kidneys to 
adult recipients amounted to 80% of the maximally attainable 
level, that is, the GFR of a single kidney remaining after 
contralateral nephrectomy. Studies concerning the long-term 
changes in the GFR of transplanted kidneys have not been 
reported. GFR measurements taken shortly after renal trans-
plantation showed a reduced GFR up to 6 hours [2] or 15 hours 
(3] after the operation. At that time the GFR amounted to 60 to 
70% of the control value. Studies covering a longer period did 
not indicate that damage had occurred to the kidney during 
transplantation [6], even after two hours of cold ischemia [7], 
according to the postoperative serum creatinine levels up to 16 
days after transplantation. Serum creatinine and urea, however, 
are not very sensitive measures to identify minor changes in 
renal function. Normal or near normal creatinine and urea 
levels may cover a wide range ofGFR values [17]. During long-
term studies near normal [4] or elevated [5]levels of blood urea 
after isogeneic kidney transplantation have been reported, 
suggesting that some degree of renal damage had occurred. 
Several factors may be involved in the observed reduction in 
the GFR when compared with the maximally attainable level. It 
is not probable that an incomplete compensatory response of 
the transplanted kidneys causes the reduction in the GFR. After 
the transplantation of already hyperfunctioning kidneys, the 
level of the GFR was almost indistinguishable from that of rats 
with a normal kidney transplant. This observation suggests that 
the transplanted kidney is partially damaged. Damage due to 
rejection can be excluded, since the kidneys were transplanted 
between male rats of a highly inbred strain, in which permanent 
survival of intra-strain skin-, heart-, and kidney grafts had been 
obtained [14, 15]. 
Therefore, it is most likely that the approximate 20% impair-
ment in the GFR of isogeneically transplanted rat kidneys is 
caused by the transplantation procedure. We speculate that, 
apart from the damaging effect of the temporary ischemia, 
ureteral obstruction occurring after the transplantation is of 
importance. This opinion is based on several observations. The 
W A GIRo recipients of WAG/Ro donor kidneys generally did 
not survive kidney transplantation for more than a week when 
their own kidneys were removed at the same time. During this 
period no urine was excreted. Clearance studies with chromium 
51-EDTA a few hours after transplantation showed that the 
kidneys did filtrate, but no radioactive material appeared in the 
bladder. Furthermore, those transplanted kidneys (N = 20) 
subjected to an IVP at the end of the followup period all 
revealed a moderate to severe degree of hydronephrosis. All 
these findings point, in our opinion, to urinary outflow prob-
lems as a possible cause for renal damage observed in this 
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Fig. 3. A The glomerular filtration rate (GFR) and B the GFR per 100 g 
body wt of normal and hyperfunctioning adult kidneys transplanted 
isogeneically to juvenile rat recipients compared with that of unilateral-
ly nephrectomized rats. Symbols used are: .11.--.11. Y NX (12); 0--0 
Y TXN (13); ._. Y TXH (7). For further explanation of abbrevia-
tions. see the legend for Figures 1 and 2. 
particular model of rat kidney transplantation. The degree of 
GFR reduction was in the same order as that of kidneys which 
had recovered from a complete ureteral obstruction of a one-
week duration [19]. 
Mter the transplantation of normal adult kidneys to juvenile 
recipients, we observed a significant decrease in the GFR, 
which was even more marked when hyperfunctioning kidneys 
were transplanted. This decrease in the GFR could be due to a 
greater damage brought about during and after the transplanta-
tion. The transplantation of adult kidneys to juvenile rat recipi-
ents, however, did not cause additional microsurgical prob-
lems, nor did the ischemic time differ from that of kidneys 
transplanted to adult recipients. Furthermore, during the fol-
lowup period the juvenile rats reached adulthood, and the BW 
40 
Table 3. Systolic blood pressure after isogeneic kidney transplantation 
in rats" 
Group codeb N< mmHg 
ANX (10) 121 ± 2 
ATXN (8) 113 ± 4 
ATXH (6) 120 ± 4 
YNX (12) 129 ± 4 
YTXN (13) 118 ± 3 
ATXH (7) 127 ± 4 
a Mean ± SEM of 10 to 12 blood pressure determinations taken 
between 6 and 12 weeks after transplantation. 
b For abbreviations see Table 1. 
c N represents the number of rats in each group. 
amounted to over 300 g. At that time the GFR was of the same 
order as that of adult recipients, indicating that the degree of 
renal damage was also of the same order. Thus, we conclude 
that the initial GFR decrease in transplanted adult kidneys is the 
result of a rapid adaptation to the size of the immature recipient 
rat. 
In rats, the GFR per 100 g BW of single kidneys remaining 
after contralateral nephrectomy increases to about 70 to 80% of 
the two-kidney value in a relatively short period [17]. The GFR 
of transplanted kidneys amounted to a level of about 80% of 
that of single hyperfunctioning kidneys in adult as well as in 
juvenile recipients. Assuming that the 20% impairment of the 
GFR is due to damage caused during and after the transplanta-
tion, it appears that the GFR of transplanted adult kidneys is in 
one way or another influenced by the recipient. Thus, the 
present findings provide evidence that, in the case of a success-
ful transplantation, the GFR is not determined by the previous 
function of the undamaged donor kidney. The transplanted 
kidney, however, behaves like a single kidney of the recipient in 
establishing the ultimate GFR level. 
No clinical data substantiating these findings in human trans-
plantation are known to us. However, conversely juvenile 
kidneys should adapt rapidly when transplanted to adult recipi-
ents. In rats a rapid increase in size has been noted after the 
transplantation of "baby" rat kidneys to adult recipients [20]. 
In human transplantation a rapid increase in renal function has 
been reported to occur when kidneys were transplanted from 
(very) young children to adult recipients [21, 22]. 
Hypertension, which is a common finding after clinical renal 
transplantation [9-11]. was not observed in rats with isogenei-
cally transplanted kidneys. This finding indicates that the 
presence of a kidney transplant as such, in this model, does not 
cause a rise in blood pressure. Thus other factors, such as 
rejection and immunosuppressive therapy, may, be of impor-
tance in raising the blood pressure level. 
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CHAPTER 3 
ALLOGENEIC KIDNEY TRANSPLANTATION AFTER ACTIVE IMMUNOLOGICAL 
ENHANCEMENT: A MODEL TO STUDY POST-TRANSPLANTATION 
HYPERTENSION IN RAT RENAL ALLOGRAFT RECIPIENTS 
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Summary 
1. A model was developed to study post-
transplant hypertension after allogeneic kidney 
transplantation between two inbred normotensive 
rat strains. Prolongation of graft survival was 
achieved by 'active immunological enhancement'. 
2. Renal function, systolic blood pressure and 
plasma renin concentration were determined. 
3. The systolic blood pressure started to rise 
in the second week after allogenek transplanta-
tion. The glomerular filtration rate was impaired 
to a greater extent than the effective renal plasma 
flow. 
4. Histopathological changes occurred indicat-
ing immunological reactions in the renal graft. 
5. The plasma renin concentration was lower 
in transplant recipients than in controls. 
6. We hypothesize that retention of sodium is 
mediately involved in the post-transplant hyper-
tension observed in this model. 
Key words: experimental surgery, hypertension, 
immunological enhancement, kidney transplanta-
tion. 
Introduction 
In renal transplant recipients hypertension is a 
frequent complication. Periods of elevated blood 
pressure have been reported to occur in large num-
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hers of adult [1] as well as paediatric transplant 
recipients [2]. 
Various factors may be involved in post-trans-
plant hypertension [3]. These include transplant 
artery stenosis, high doses of corticosteroids, acute 
and chronic allograft rejection, recurrence of the 
original disease and the presence of the recipient's 
own diseased kidneys. Disordered functioning of 
the renin-angiotensin system or persistent volume 
expansion may play a part in the post-transplant 
hypertension [4, 5]. 
Experimental renal transplantation in rats has 
been used to assess the role of the kidney in the 
pathogenesis of the blood pressure elevation in 
genetically hypertensive strains [6, 7]. Up till now, 
no model has been developed to study post-trans-
plantation hypertension in rats with normotensive 
donors and recipients. In a previous study [8] it 
was shown that hypertension did not develop after 
isogeneic rat kidney transplantation. In the present 
experiment we determined the effect of allogeneic 
kidney transplantation on renal. function and 
blood pressure in rats. 
Methods 
Laboratory animals 
Adult male rats (body weight 250-300 g) of 
highly inbred Wistar (W AG/Ro) and Brown Norway 
(BN) strains were used for the transplantations. 
These rat strains differ at the major histocompati-
bility locus. The WAG/Ro is RT-JY, the BN strain 
is RT-1". The animals had unlimited access to food 
(Rat chow AM II, Hope Farms, containing 120 
mmol of Na/kg) and tap water (containing 3 mmol 
ofNa/1). 
Surgery 
A microsurgical technique, as described before 
[8], was used for rat renal transplantation. BN rats 
were used as donor, WAG/Ro rats as recipients. It 
is known that BN rats may develop spontaneous 
hydronephrosis [9]. Consequently, their renal 
function may be unequally divided over both 
kidneys. Since we wanted to know the pretrans-
plant renal function of the donor kidney, intact 
kidneys had to be selected. When an intact kidney 
was present in the potential donor rat, the left 
kidney was removed 3 weeks before transplanta-
tion. In this way a compensatory hyperfunctioning 
donor kidney was transplanted. In the isogeneic 
rat model, developed previously, there were no 
major differences when comparing the transplanta-
tion of a normal or a hyperfunctioning kidney [8]. 
In allogeneic kidney transplantation the recipient's 
own kidneys were removed during the transplant 
operation. 
Analytical procedures 
The glomerular filtration rate (GFR) and the 
effective renal plasma flow (ERPF) were measured 
as clearances of 51Cr-labelled EDTA and of [125I]-
iodohippurate (125I-IOH) respectively. The method 
has been described in detail elsewhere [ 1 0]. I 11 the 
BN rats it was necessary to determine the volume 
of distribution (V) of 51Cr-labelled EDTA and of 
125I-IOH, to be able to calculate the GFR and the 
ERPF in this rat strain. In seven rats, with a body 
weight of 283 ± 29 g (mean ± SD ), the V of 51Cr-
labelled EDTA was found to be 23.0 ± 0.7% of 
body weight and that of 125I-IOH 25.3 ± 1.6% of 
body weight. 
The plasma renin concentration (PRC) was 
measured with a radioimmunoassay for angiotensin 
I (ANG I) after incubation of the plasma sample 
with excess rat renin substrate at pH 6.5 [11]. 
Plasma concentrations of creatinine (Per) and 
urea (Pur) were determined with a Gilford auto-
analyser. 
Systolic blood pressure was generally deter-
mined in conscious rats by means of tail plethys-
mography (Electro-sphygmomanometer PE 300 
Narco Bio-System). In BN donor rats the assess-
ment of normal systolic blood pressure values was 
not possible without anaesthesia. This strain could 
not be trained to sit stili in the restraining cages. 
Consequently, the systolic pressure was measured 
under pentobarbital anl\esthesia ( 60 mg/kg intra-
peritoneally) in a separate group of BN rats and 
compared with that of a group of pentobarbital 
anaesthetized W AG/Ro rats. 
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Expen·mental protocol 
To prolong allograft survival, and to circum-
vent the use of corticosteroids, active immunologi-
cal enhancement was used, which had been shown 
to be successful in this model [12]. To induce 
enhancement all W AG/Ro rats were given an 
intravenous injection of 1 ml of fresh citra ted BN 
rat blood 2 weeks before transplantation. Three 
groups of rats were studied. The first group initially 
consisted of 15 WAG/Ro rats with a technically 
successful (i.e. survival for at least 7 days) BN 
kidney transplant. Of these 15 rats, nine survived 
for a period of over 21 days. In the analysis, these 
nine remaining rats of this group were compared 
with a second group of seven unilaterally nephrec-
tomized (NX) W AG/Ro rats and a third group of 
six intact WAG/Ro rats. 
The systolic blood pressure was measured three 
times a week, starting at least 1 week before trans-
plantation. The GFR and the ERPF were deter-
mined before transplantation as well as 1 and 3 
weeks after transplantation. Fifteen minutes after 
the induction of pentobarbital anaesthesia and 
before the injection of 51Cr-labelled EDTA and 
1251-IOH, 400 JL1 of blood was sampled to determine 
the PRC, Per and Pur values. 
Histology 
In a separate group of transplant recipients, 
animals were killed at various times after trans-
plantation. The kidney was fixed in 4% buffered 
formaldehyde solution. The fixed tissue was 
dehydrated with ethanol and embedded in Paramat. 
Serial sections were cut to a thickness of 3-4 J.Lm. 
Sections were stained with haematoxylin-eosin. 
Statistics 
Results are given as means± so. The divergence 
between the groups was determined by one-way 
analysis of variance (ANOV A). 
Results 
The GFR and the ERPF ofWAG/Ro recipients of 
BN kidneys, NX and control rats, as well as those 
of BN donor rats, are given in Table 1. The GFR 
and the ERPF of the single compensatory hyper-
functioning BN kidney amounted to, respectively, 
59% and 72% of the two intact kidneys ofWAG/Ro 
recipient rats. 
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TABLE I. Pre-transplant renal function of recipients and control groups of WAGjRo 
rats, and of unilaterally nephrectomized BN donor rats 
All results are means± SD (n is the number of rats). TX, (Pre-operative) transplant 
recipients; NX, (pre-operative) unilaterally nephrectomized rats; C, intact control 
rats; BN, kidney donor rats. 
Group Bodywt. GFR ERPF Ratio 
(n) (g) (ml/min) (ml/min) GFR/ERPF 
TX (9) 245 19 2.00 ± 0.10 5.09 ± 0.30 0.35 ± 0.02 
NX(7) 243 16 2.09 ± 0.26 5.14 ± 0.61 0.41 ± 0.04 
Control (6) 246 21 1.97 ± 0.24 4.93 ± 0.35 0.40 ± 0.04 
BN (9) 283 22 1.18 ± 0.29 3.67 ± 0.82 0.31 ± 0.04 
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FIG. 1. Systolic blood pressure of allogeneic kidney recipients (A), of unilaterally 
nephrectomized (NX: o) and of two-kidney control (e) rats. 
Systolic blood pressure 
Fig. I shows the mean systolic blood pressure 
of the transplant recipients, the NX and the control 
WAG/Ro rats from I week before transplantation 
up to 4 weeks post-transplantation. The mean 
systolic blood pressure of the transplant recipients 
was not significantly different from that of NX 
and control rats before or during the first week 
after transplantation. However, from day 8 on-
wards, the pressure started to increase in the 
recipients. A significantly elevated mean systolic 
pressure in rats with a kidney transplant was 
present as from day 11. The mean systolic blood 
pressure of normal BN rats under pentobarbital 
anaesthesia was 128 ± 7 mmHg, not significantly 
different from that of WAG/Ro rats, which was 
134 ± 18 mmHg under the same conditions. 
Renal function 
The GFR and the ERPF, measured I and 3 
weeks after transplantation, are given in Table 2. 
The WAG/Ro rats with an allogeneic BN kidney 
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TABLE 2. Post-transplant measurements of renal function, plasma renin concentration and systolic blood 
pressure in allogeneic kidney transplant recipients and control groups 
All results are means± so (n is the number of rats). TX, Transplant recipients; NX, unilaterally nephrec-
tomized rats; C, control rats. Significance: * P < 0.05 of TX with NX and C; ** P < 0.05 of NX with C; 
t no significant differences between TX, NX and C. 
Group Body wt. GFR ERPF GFR/ERPF Per Pur PRC Systolic 
(n) (g) (ml/min) (ml/min) (J.Lmol/1) (mmol/1) (ng of ANG I BP 
h"' ml- 1) (mmHg) 
Week 1 
TX(9) 225 ± 12* 0.39 ± 0.08* 1.95 ± 0.45* 0.20 ± 0.02* 117±25* 22±4* 21.5 ± 5.6* 148 ± 24t 
NX(7) 239± 9 1.16 ± 0.10** 3.41 ± 0.22** 0.33 ± 0.02** 53± 3** 9.4±0.7 69.0±11.4 129 ± 10 
Control 252± 15 1.88 ± 0.13 4.60 ± 0.32 0.41 ± 0.04 43 ±4 8.6 ± 1.1 60.8 ± 18.7 131±10 
(6) 
Week3 
TX(9) 224 ± 22* 0.46 ± 0.17* 2.75 ± 0.86* 0.17 ± 0.02* ll8 ± 33* 29 ± 12* 18.3 ± 2.9* 175±26* 
NX(7) 259 ± 14 1.48 ± 0.13** 4.04 ± 0.48** 0.37 ± 0.02** 61 ± 7** 9.9 ± 0.4** 54.2 ± 7.2 124 ± ll 
Control 268 ± 20 2.34 ± 0.32 5.07 ± 0.14 0.44 ± 0.02 46± 2 8.1 ± 0.3 65.2 ± 13.9 128 ± 10 
(6) 
graft had lower GFR and ERPF values than NX 
and control rats. However, the reduction in GFR 
was more pronounced than the reduction in the 
ERPF, leading to a reduction in the filtration 
fraction (GFR/ERPF ratio). The Per and Pur of 
transplant recipients were significantly higher than 
those ofNX and control rats (Table 2). 
Although there was a significant increase in the 
ERPF of the transplanted kidneys between weeks 
1 and 3, the improvement of the GFR was not 
very marked. At 3 weeks after transplantation 
the GFR amounted to 30% of NX, and to 20% of 
controls, whereas the ERPF amounted to 68% 
of NX and 54% of controls. 
Histopathology 
Allotransplanted kidneys taken from immuno-
logically enhanced recipients showed marked 
alterations when compared with BN control 
kidneys. As examples, micrographs of kidney sec-
tions taken 4, 8 and 20 days after transplantation 
and those of a control BN kidney are given in Fig. 
2 (a-<1). 
On day4, the glomeruli showed some swelling 
of the visceral epithelium. Prominent perivascular 
infiltrates of mononuclear cells were noted. The 
vascular walls as such were not affected. The 
tubular cells showed vacuolization. 
On day 8, the glomerular changes consisted of 
an increment in the cellularity and the matrix of 
the mesangium. Furthermore, the glomeruli showed 
lobulation. An increase in the interstitial infiltrate 
was also noted. 
On day 20, most of ihe glomeruli showed severe 
pathological changes with lobulation, capillary 
loop necrosis and extra-capillary proliferation. 
Furthermore a dense interstitial infiltrate was 
noted, as well as vasculitis and necrosis of vascular 
walls. 
Plasma renin concentration 
The plasma obtained from the WAG/Ro rats 
with a kidney transplant, after 15 min of pento-
barbital anaesthesia, had significantly lower PRC 
values than that of NX and control rats. Despite 
a significant increase in the systolic blood pressure, 
there was no difference in the PRC when this was 
measured at 1 and 3 weeks post-transplantation. 
In order to determine whether the low PRC values 
were intrinsic to BN kidneys, the PRC was also 
measured in unilaterally nephrectomized BN rats. 
After 15 min of pentobarbital anaesthesia, the 
PRC of these rats amounted to 73 ± 29 ng of ANG 
I h-1 ml-1. The PRC of the same rats, determined 
I week later without anaesthesia, from blood 
obtained after decapitation, was 32 ± 7 ng of 
ANG I h-1 ml-1 . 
Discussion 
Hypertension was noted to occur after allogenic 
kidney transplantation between two inbred 
normotensive rat strains. The systolic blood pres-
sure started to rise during the second week after 
transplantation and remained high for the duration 
of the study, which was completed 28 days after 
transplantation. In a previous study we have estab-
lished that hypertension does not occur after 
isogeneic transplantation within the same strain of 
rats as those we used as recipients in the present 
study [8]. That fmding indicated that the mere 
presence of a transplanted kidney, or the trans-
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FIG. 2. Micrographs from sections of a normal BN kidney (a) and of kidneys aile-
grafted into immunologically enhanced W AGfRo recipients, removed on days 4 (b), 
8 (c) and 20 (d) after transplantation. (Haematoxylin-eosin, XSOO). 
plantation procedure as such, did not cause a rise 
in blood pressure. 
Untreated WAG/Ro recipients of BN kidneys 
usually die within 2 weeks after transplantation 
[ 13]. In the present study, active immunological 
enhancement achieved with a single intravenous 
injection of donor strain whole blood [ 14] was 
successful in prolonging allograft survival in nine 
out of 15 rats. In this way the use of corticosteroids 
or other immunosuppressive agents could be 
avoided. Consequently, the hypertension we 
observed could not be due to the effect of drugs. 
Despite the prolonged survival, immunological 
reactions to the transplanted kidney were not 
entirely suppressed. Marked histopathological 
changes were seen in the allografted kidneys 
during the first 3 weeks after transplantation. 
Measurements of renal function also indicate 
extensive damage. At 3 weeks after isogeneic 
kidney transplantation (JI AG(Ro to WAG/Ro ), 
the GFR amounted to 80-85% [8], and the ERPF 
to 90-95% (A. P. Provoost & M. H. De Keijzer, 
unpublished work) of that of single, hyperfunc-
tioning kidneys after unilateral NX. In the allo-
geneic BN to WAG/Ro combination, these values 
were 3 5-40% and 80-85% respectively for the GFR 
and the ERPF. This would indicate that the pro-
cess of glomerular filtration is markedly impaired 
after allogeneic transplantation in this model. The 
functional impairment, together with the histo-
logical changes, resembles the picture of experi-
mental glomerulonephritis [15, 16]. Consequently, 
the increase in systolic blood pressure observed in 
the transplant recipients may have a nephritic 
nature, associated with sodium retention [16, 17]. 
Determination of the PRC in the transplant 
recipients revealed no increase, whereas there was 
a considerable rise in blood pressure. The PRC of 
transplant recipients was even significantly lower 
than that of control rats. The PRC was measured 
in plasma obtained after 15 min of pentobarbital 
anaesthesia, which is known to stimulate renin 
release [18]. Unilaterally nephrectomized BN rats 
showed a normal increase in the PRC during 
pentobarbital anaesthesia. One might argue that in 
denervated transplanted BN kidneys renin release 
was not stimulated by pentobarbital. However, the 
fact that the transplanted kidneys are denervated 
cannot play an important part, since we have 
found that the pentobarbital-stimulated renin 
release was independent of an intact sympathetic 
nervous system [18]. Furthermore, the PRC of 
transplant recipients was even lower than that of 
unstimulated values, obtained after decapitation in 
unilaterally nephrectomized BN rats. 
It is a well-known fact that the PRC is reduced 
during high sodium intake or after sodium reten-
48 
tion. The release of renin from the kidney was 
found to be inversely related to the sodium load 
sensed by the macula densa cells in the distal 
tubule [19]. Consequently, we think that the re-
duced PRC observed in the transplant recipients 
might well be the result of the retention of sodium 
and an expansion of the extracellular fluid volume. 
In conclusion, the hypertension observed in this 
particular model, after renal transplantation in 
rats, might be mediated by sodium retention as 
a result of immunological alterations in the kidney. 
Further studies are being carried out to test this 
hypothesis. 
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TRANSPLANTATION HYPERTENSION IN RAT RENAL ALLOGRAFT RECIPIENTS 
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Abstract. Hypertension secondary to renal transplantation was studied in our experimental model in the rat. In this 
model an intravenous injection of donor strain blood into recipients of allogeneic donor kidneys prior to transplanta-
tion was used to prolong the allograft survival. A reduced renal function associated with the hypertension was 
suggestive of incomplete prevention of the rejection process. We studied the effect of cyclosporin A, either alone or as 
adjuvant immunosuppressive therapy, on renal function and systolic blood pressure. Either way, cyclosporin A 
resulted in normotensive allograft recipients and in a better function of the graft when compared with recipients 
pretreated with donor strain blood only. 
Introduction 
In man, hypertension is a common complication of a 
surgically successful kidney transplantation. The hyper-
tension is usually attributed to various factors [1], the 
relative contribution of which is not easy to establish in 
man. Recently we developed an experimental model to 
study hypertension following allogeneic kidney trans-
plantation in rats. Treatment with donor strain blood 
prior to transplantation was used to prolong graft sur-
vival. This posttransplantation hypertension was asso-
ciated with a reduced renal function and a low plasma 
renin concentration [2]. The latter was considered to 
result from sodium retention, and in a subsequent experi-
ment it was shown that a reduction in the daily sodium 
intake prevented the development ofhypertension [3]. 
The reduced renal function and the observed histo-
pathological changes [2] indicated an incomplete preven-
tion of the rejection process by the pretreatment with 
donor strain blood. Consequently, we wanted to study 
the effect of additional immunosuppression upon the 
renal function and the systolic blood pressure (SBP) in 
our model. Clinically, a combination of azathioprine and 
corticosteroids is most frequently used to prevent rejec-
tion. Steroids, however, are hypertensiogenic themselves 
[4, 5]. Recently, cyclosporin A (CsA) proved to be a 
powerful immunosuppressive [6], effective in experimen-
tal kidney transplantation [7-9] as well as in human 
transplantation [10]. To avoid the use of corticosteroids, 
CsA was used to improve immunosuppression in our 
allogeneic kidney transplantation model in rats. 
Materials and Methods 
Laboratory animals consisted of adult male rats with a body 
weight (BW) of250-300 g of highly inbred Wistar (WAG/Ro) and 
Brown Norway (BN/Ro) strains. These strains differ at the major 
histocompatibility locus. The rats had free access to tap water and 
food (rat chow AM II, Hope Farms, containing 120 mmol sodium/ 
kg). 
The BN rats were used as kidney donors, WAG rats as recipients 
and as unilaterally nephrectomized controls. Potential kidney do-
nors, i.e., BN rats without an apparent hydronephrotic right kidney, 
had their left kidney removed 3 weeks before transplantation. In this 
way a compensatory hyperfunctioning kidney was transplanted. A 
number of WAG recipients and controls received an intravenous 
injection of I ml of fresh citrated BN donor strain blood 2 weeks 
prior to transplantation or unilateral nephrectomy. All recipients 
were subjected to bilateral nephrectomy of the native kidneys at the 
time of transplantation. Transplantation was performed under ether 
anaesthesia, utilizing a microsurgical technique as previously de-
scribed [111. 
The CsA was administered intramuscularly at a dose of 15 
mg/kg on days 0, 4, and 7 after transplantation. Before administra-
tion CsA was dissolved in olive oil by heating it to 60°C. 
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renal transplantation was considered technically successful if the 
recipient rats survived for at least 7 days. 
Group I initially consisted of 14 rats, group 2 of 12, group 3 of 6, 
and group 4 of 12 rats. Only data from rats surviving for 6 weeks, 
* except those from group 3, were included in the statistical analysis 
ofthe differences in SBP or renal function. The different groups of 
allograft recipients were also compared with groups of 6 unilaterally 
nephrectomized (NX) control rats receiving identical treatments. 
The SBP was measured 6 days per week, starting 1 week before 
operation and continuinguntil6 weeks after operation. The glomer-
ular filtration rate (GFR) and the effective renal plasma flow 
(ERPF) were determined before transplantation in the BN donor 
rats and 1, 3, and 6 weeks after operation in transplant recipients and 
in unilaterally nephrectomized controls. At the end of the follow-up 
period, the kidneys were weighed and the number of glomeruli of 
transplanted and control kidneys counted. 
Measurements 
Fig. 1. SBP of renal allograftrecipientrats on different immuno-
suppressive regimens. Tx=Transplantation; 11-group 1. donor 
strain blood pretreatment; • =group 2, donor strain blood pretreat-
ment plus CsA; • =group 3, CsA alone, Asterisks denote signifi· 
cant difference from groups 2 and 4 (p < 0.05). 
Systolic Blood Pressure. The SBP of non-anaesthetized animals 
was determined by tail plethysmography (electro sphygmoma-
nometer; Narco Bio System, Houston, Tex., USA). At least three 
SBP readings were taken to obtain the average daily SBP. The SBP 
data are given as an average of three consecutive daily values. 
Renal Function. GFR and ERPF were measured as clearances of 
51Cr-EDTA and 1251-iodohippurate, respectively. This method has 
been descn"bed in detail elsewhere [11, 12]. At the time of the renal 
function measurement, 200 ~blood was sampled to determine the 
plasma concentrations of creatinine (P cr) and urea (Pur)· P cr and Pur 
were determined by kinetic techniques with the use of an auto-ana-
lyzer. Experimental Protocol 
Recipient rats were divided into 4 groups: group I was pretreated 
with donor strain blood, but received only olive oil after transplan· 
tation; group 2 animals were pretreated with donor strain blood and 
with CsA in olive oil after transplantation; group 3 had no pretreat· 
ment and received only olive oil, and group 4 animals had no 
pretreatment and received CsA in olive oil after transplantation. A 
Glomeruli were counted after staining with India ink according 
to a modification [13] of the method of Damanian et a!. [14]. 
Statistics 
Differences in mean values between groups were compared by 
one-way analysis of variance. In case of significant differences (i.e., 
Table I. Pre-operative and posttransplant renal functional parameters in allogeneic transplant recipients on different immunosuppres-
sive regimens 
Pre-operative Weeki 
group I group2 group3 group4 group I group 2 
don rec don rec don rec don rec 
(n=9) (n=9) (n=9) (n=9) (n=6) (n=6) (n=8) (n=8) (n=9) (n=9) 
BW,g 250 ± 19 289 ±28 268 ± 19 293 ±21 264±21 290±17 252±27 297 ±33 264 ± 31 264±22 
SBP,mmHg 130±9 132± 13 132±3 134±4 137± 12 126± II 
GFR,mllmin 1.04± 0.22 1.13 ± 0.14 1.04±0.25 1.04±0.23 0.74±0.25 0.69± 0.20 
GFR,o/oNX 63 57 
ERPF, ml/min 3.33 ± 0.65 3.91 ±0.44 3.65 ±0.80 3.35 ± 0.56 3.25 ± 0.99 3.00±0.64 
ERPF,o/oNX 97 87 
Pa,l'ffiOlll 64±3 65±3 67±5 65±3 82± 15 95±41 
P.,,mmol/1 13.1 ± 1.1 13.5 ± 1.6 14.9 ±2.8 14.2± 1.8 17.4±5.5 16.8 ±3.7 
Non-survivors. 
Data are mean values± SD; Don- donor; rec-recipient;% NX- percentage of unilaterally nephrectomized controls; *p < 0.05 when 
compared with group I. 
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an F value indicating a probability less than 0.05), the Newman-
Keuls test was used to fmd which pair(s) of means were different 
[15]. To test statistical differences in survival rates between the 
groups, the x2 test was used. 
Results 
Systolic Blood Pressure 
The SBP of allograft recipients of groups 1, 2, and 4 is 
depi~ed in figure 1. Recipients who were pretreated with 
donor strain blood only (group I) showed an increase in 
SBP after transplantation. The SBP started to rise I week 
after transplantation and remained elevated till the end 
of the 6-week follow-up period. Kidney transplant reci-
pients receiving either CsA in additional to donor blood 
pretreatment (group 2) or CsA alone (group 4) remained 
normotensive throughout the observation period. Com-
pared with these two groups, recipients in group I showed 
a significantly higher SBP during the follow-up period. 
There were no statistical differences in SBP between 
recipients in groups 2 and 4 and in comparison with 
unilaterally nephrectomized rats regardless the treat-
ment. The recipients that had neither pretreatment with 
blood nor CsA (group 3) all died within"IO days. Although 
they remained normotensive for that short period of 
survival, their SBP started to rise at the end of the 1st week 
after transplantation. 
Renal Function 
Pre-operative BW and SBP of the four groups of 
recipients and renal functional parameters and BW of the 
corresponding donor rats are given in table I. This table 
Week3 
group3 group4 group I group 2 group3 
(n=6) (n=8) (n=9) (n=9) (n=6)' 
264± 13 269±24 264± 23 271 ± 14 
138 ± 13 127±8 165± 19 123 ± 8* 
0.19 ±0.08 0.64 ± 0.15 0.44±0.23 0.79±0.28* 
17 50 37 65 
036± 023 2.87±0.72 2.82± 0.99 3.45 ± 0.84 
II 88 71 94 
536±273 83± 13 87±34 70±8* 
94.0±35.9 16.8 ±3.0 27.0 ± 16.6 13.9 ± 2.5* 
also lists renal function parameters, BW and SBP of each 
group of recipient rats determined 1, 3, and 6 weeks after 
transplantation. 
1 week after transplantation no statistical differences 
were found in the GFR or ERPF of recipient rats which 
received either donor strain blood alone or CsA alone or 
a combination of both. After the 1st week, the recipients 
of groups 2 and 4 showed an improvement of their GFR, 
while there was a decrease in GFR of recipients in group 
1. After week 3 the GFRofthe rats in this group improved 
again, but remained significantly lower than the GFR of 
recipients in groups 2 and 4. No differences in the ERPF 
between recipients in groups 1, 2 and 4 were noted 
throughout the follow-up period. Recipients in group 3 
had a very low GFR and ERPF at the end of the 1st week 
after transplantation. When expressed as a percentage of 
the donor GFR, the GFR of the recipients in group 1 was 
70% at week I, 43 at week 3, and 69% at week 6. The GFR 
of recipients in groups 2 and 4, respectively, was 59 and 
62% of the donor GFR at week I and steadily increased to 
86 and 116% at week 6. Expressed as a percentage of the 
donor ERPF, the ERPF of the recipients in group I was 
98% at week I, 85 at week 3, and 99% at week 6. The 
percentages of the recipients in groups 2 and 4 were, 
respectively, 77 and 86% at week I, 88 and 97% at week 3, 
and 98 and 132% at week 6. 
Number of Glomeruli 
The number of glomeruli present in transplanted kid-
neys of recipients in group I was less in comparison with 
that of recipients in groups 2 and 4. The number 
amounted to 27,920 ± 9,297 in group 1 against 
Week6 
group4 group I group 2 group3 group4 
(n=8) (n=9) (n=9) (n=6)' (n=8) 
283 ± 19 276 ±25 283 ± 18 300±23 
118 ± 10* 160 ± 34 123 ± 13* 122 ± 14* 
0.82±0.20* 0.71 ± 0.40 0.98±0.13* 1.20±0.31* 
66 57 81 95 
3.24± 1.02 3.30 ± 1.34 3.81 ± 0.55 4.42±0.46 
85 88 106 113 
71 ±6* 98±71 71 ±8 68±8 
12.9 ±0.9* 27.1 ±25.9 15.7 ±4.2 13.0± 1.2 
54 
33,523±5,083 in group 2 and 31,984±3,838 in group 4. 
There was no statistical difference between the recipients 
of groups 2 and 4 and the unilaterally nephrectomized 
control rats. We also counted the glomeruli of 2 mori-
bund allograft recipients in group 3. These kidneys had 
10,290 and 11,520 glqmeruli which was about 30% of the 
glomeruli of controls. 
Survival Rate 
All transplant recipients of group 3 died before day 11 
after transplantation. During the 6-week observation pe-
riod several transplanted rats from the other three groups 
were also lost due to rejection. 5 (36%) of the 14 techni-
cally successful transplanted rats died in group I; 3 (25%) 
of the 12 rats in group 2, and 4 (33%) of the 12 rats in group 
4 did not complete the follow-up period. There were no 
statistically significant differences in mortality rates be-
tween those latter groups {X2 test). 
Discussion 
In experimental kidney transplantation in rats, iso-
graft recipients remained normotensive [11], while hyper-
tension developed in allograft recipients pretreated with 
donor strain blood to prolong graft survival [2]. This may 
have been due to incomplete suppression of rejection. In 
the present study the use of the potent immunosuppres-
sive CsA [6], as adjuvant therapy as well as alone, pre-
vented the development of hypertension after allogeneic 
kidney transplantation. The recipients treated with CsA 
also had a better renal function, and, at the end of the 
6-week follow-up period, more glomeruli were present in 
the allografts when compared with recipients pretreated 
with donor strain blood only. These findings demon-
strate that a better immunosuppression was achieved by 
the use of CsA. With improved immunosuppression the 
recipients remained normotensive as previously reported 
for recipients with isogeneic kidney transplants [11]. 
In human recipients, hypertension following renal 
transplantation has been attributed to various factors[!]. 
Among the most frequently mentioned are renal trans-
plant artery stenosis, presence of the diseased native 
kidneys, rejection, and the use of corticosteroids. Since 
no diseased native kidneys were present, and corticoste-
roids were not used in the present experiment, these 
factors can be excluded as a cause for hypertension in this 
model, nor is transplant renal artery stenosis likely to be 
involved here. The transplantation technique, using end-
to-side anastomosis, is not prone to the development of 
artery stenosis. Furthermore, the blood pressure re-
sponse to a reduction in salt intake and the presence of an 
intact native kidney convinced us that the posttransplan-
tation hypertension model was at variance with the 1-kid-
ney-1-clip Goldblatt hypertension in rats [3]. Conse-
quently, rejection remains as the most likely cause for the 
rise in SBP. 
After stimulation of the host's immune system, rejec-
tion is the result of a combined attack on the allograft by 
several arms of the immune response. Rejection consists 
of a number of processes, tackling the graft in a different 
way, and each probably capable of graft destruction by 
itself. After transplantation, rejection has been classified 
as hyperacute, acute, or chronic. These terms are not well 
defined and refer not only to the relationship between 
rejection and the time elapsed after transplantation, but 
also to the rate of functional deterioration of the allo-
graft. Another classification is based on the effector 
mechanism of the immune response. Following cellular 
infiltration of the graft by a mixture ofT and B lympho-
cytes, macrophages, and polymorphonuclear cells, graft 
rejection may occur by direct cell-media.ted killing or 
through the production of antibodies. The cellular type 
of rejection involves mainly the T lymphocytes, whereas 
the humoral response is mediated by B lymphocytes, 
albeit T cell dependent: The chronic rejection process is 
usually attributed to damage caused by antibodies. 
The cellular and humoral types of rejection may differ 
in their response to various immunomodulating agents. 
Pretreatment of the recipient rats with donor strain blood 
partially prevents the rejection reactions. The greatest 
effect is on the cellular response, although the humoral 
response is also diminished [16]. After allogeneic kidney 
transplantation in recipients pretreated with donor strain 
blood, the histopathological findings in the allografts are 
consistent with chronic rejection [2]. Although the precise 
action ofCsA is not completely known, the main effect of 
CsA is directed to the cellular mediated immune re-
sponse, probably due to a selective action on helper T 
lymphocytes [6, 8, 17, 18]. Through these cells inhibition 
of B cell antibody production may occur as well. Conse-
quently, while the action of CsA involves the same target 
as pretreatment with donor strain blood, it is much more 
effective. This may explain the apparent Jack of syner-
gism between CsA and donor strain blood pretreatment. 
The use of CsA alone was as effective as the combination 
of CsA and donor strain blood pretreatment. 
From the present and previously published results [2, 3, 
11] we postulate that in our rat model of postrenal trans-
plantation hypertension the increase in SBP is the result of 
the following chain of events. Pretreatment with donor 
strain blood partially suppresses the rejection process, 
leading to a chronic type of rejection. Structural damage 
within the allograft due to i=unological reactions will 
cause functional alterations. As a result of these changes, 
the transplanted kidney has an intrinsic deficiency in the 
excretion of the daily sodium intake at a normal blood 
pressure level. Accumulation of sodium will cause a vol-
ume-dependent hypertension. Either sodium restriction or 
the prevention of chronic rejection, i.e., a more successful 
immunosuppression, should prevent the development of 
hypertension. As shown in the present and a previous 
study [3] we found both to be effective. 
Some of the general concepts of rejection may be 
applicable to man. The human situation, however, ap-
pears far more complex than that observed in rats. In the 
rat short courses ·of immunosuppression are generally 
sufficient for prolonged allograft survival. Three injec-
tions with CsA up to I week after transplantation resulted 
in good functioning grafts. In man, most immunosup-
pressives are administered as long as a functioning graft 
is present. Cessation of the treatment usually results in 
rejection, indicating that the antigenic stimulation an-
d/ or the immune response in man is much stronger than 
in the rat. 
In clinical studies, renal transplant recipients treated 
with CsA showed neither a lower incidence nor a less 
severe form of hypertension when compared with reci-
pients treated with a combination of azathioprine and 
prednisolone [19-21]. The reason for this divergence from 
our findings in rats may be twofold. Firstly, in these 
studies renal function was generally reduced in the CsA-
treated recipients. This is inost likely due to CsA nephro-
toxicity [22, 23]. However, it is difficult to differentiate 
between nephrotoxicity and rejection [23, 24]. Therefore, 
a less effective prevention of chronic rejection is also 
possible. Secondly, recent findings point to a direct effect 
of CsA on blood pressure. In rats an acute, albeit tran-
sient, increase in blood pressure has been noted during 
CsA infusion [25]. Chronic administration of CsA at a 
dose of 20 mg/kg was found to attenuate hypertension in 
spontaneously hypertensive rats [26]. This increase in 
SBP was associated with an increased plasma renin activ-
ity. Furthermore, in cardiac transplant recipients receiv-
ing CsA, there is an almost universal development of 
systemic arterial hypertension [27, 28], while this was less 
than 20% in patients receiving azathioprine plus prednis-
olone. The absence of hypertension in CsA-treated rats in 
the present experiment may be due to the very short 
duration of the treatment. 
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These findings indicate that extrapolation of the 
experimental results to the clinical situation has to be 
done with great care. Due to the strongerimmunogenicity 
of man as compared with rats, chronic rejection pheno-
mena may be present despite continuous i=unosup-
pressive treatment. In our model adequate i=unosup-
pressive treatment resulted in well-functionning grafts 
and normotensive allograft recipients. In man, despite 
stable graft function with continuous immunosuppres-
sion, hypertension frequently occurs. This may indicate 
that the immunosuppression is still insufficient, or the 
drugs used have hypertensive properties. 
In conclusion, our experimental research demonstrat-
ed that postrenal transplantation hypertension is secon-
dary to insufficient i=unosuppression. In view of post-
transplantation salt retention, a peri-operative low salt 
intake is recommended. Experimentally, the use of CsA 
successfully suppressed rejection, and hypertension did 
not occur. Since clinical results differ from these find-
ings, there is still room for improvement of the antirejec-
tion treatment in human renal transplantation. 
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SUMMARY 
Rat recipients of renal allografts 
nephrectomized control rats were studied 
response in blood pressure to prednisolone 
and unilaterally 
to evaluate the 
in diverse doses 
and to determine the dosage required to achieve adequate 
immunosuppression without undue complication of hypertension. 
While a continuous infusion of 2 mg/kg/day or more of 
prednisolone proved effective in prolonging allograft survival 
time, this dosage increased the blood pressure of recipients 
as well as unilaterally nephrectomized control rats. In 
contrast to control rats, the recipients remained hypertensive 
after the cessation of prednisolone administration. This 
suggests that the high blood pressure observed during 
prednisolone administration was due to its hypertensive 
action. On the other hand, the high blood pressure remaining 
after cessation of the prednisolone administration is likely 
to be caused by an incomplete prevention of rejection. If 
recipients had received a transfusion of donor strain blood 
prior to transplantation in combination with the infusion of 2 
mg/kg/day or more of prednisolone, they became normotensive 
when the prednisolone infusion was ceased. By reducing the 
prednisolone dosage to 1 mg/kg/day in combination with donor 
strain blood pretreatment, hypertension could also be 
eliminated during the first two weeks. In conclusion, 
effective immunosuppression can be achieved with prednisolone 
in rats, without inducing hypertension, provided prednisolone 
is administered in a low dose in combination with adjuvant 
immunosuppression, i.e. donor strain blood pretreatment. 
60 
INTRODUCTION 
In previous studies we have found that pretreatment with 
donor strain blood (DSB) prolongs the survival time of rats 
after renal allotransplantation. A relatively low renal 
function 
rejection 
in the 
indicated that there was only partial suppression of 
(1,2). Incomplete prevention of rejection resulted 
development of hypertension. With additional 
immunosuppression, e.g. by administering Cyclosporin A, the 
recipient rats remained normotensive throughout the 
observation period with a good renal function (3). We also 
found that a low sodium diet would prevent a rise in blood 
pressure after transplantation, suggesting that the retention 
of sodium might be a precursor of the observed hypertension 
( 2). 
In humans, hypertension is a common complication of renal 
transplantation in the immediate and subsequent post-operative 
period. Prednisolone is a substantial element in almost every 
human immunosuppressive regimen. As this drug raises the blood 
pressure, it is generally assumed that post-transplantation 
hypertension is a side-effect of the steroid medication (4,5). 
The effects on blood pressure and immunosuppression of 
prednisolone either with or without adjuvant immunosuppressive 
treatment (DSB) were studied in our rat model of post-
transplantation hypertension. We wanted to determine to what 
extent the immunosuppressive effect of DSB would enable 
lowering the prednisolone dosage, resulting in a normotensive 
recipient. In previous experiments we found that a continuous 
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infusion of prednisolone would enhance the immunosuppressive 
effect as compared with single daily injections (6). We now 
studied the effects of a continuous infusion of prednisolone 
either with or without DSB pretreatment upon blood pressure 
after allogeneic kidney transplantation in rats. 
MATERIAL AND METHODS 
u 
Adult male rats of the inbred WAG/Ro (RT-1 ) and BN/Ro 
n 
(RT-1 ) histo-incompatible strains, weighing 250-300 g, were 
used. The rats had free access to tap water and food (Rat chow 
AM II, Hope Farms, Woerden, The Netherlands) containing 120 
mmol sodium per kg. 
Surgery 
The microsurgical technique of Fisher and Lee (7) with a 
modification of the bladder-ureter anastomosis was used for 
heterotopic kidney transplantation. The recipients native 
kidneys were removed at the time of transplantation. Control 
WAG/Ro rats had a unilateral nephrectomy through an abdominal 
approach. 
Blood for donor strain blood (DSB) pretreatment was 
obtained from adult BN/Ro rats by cardiac puncture. Two weeks 
before transplantation, WAG/Ro recipients received 1 ml of 
fresh citrated BN blood intravenously. Prednisolone (Di-
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Adreson-F aquosom, Organon, Oss, The Netherlands) was 
administered in diverse doses as a constant, 24-hour, 
subcutaneous infusion during two weeks, by means of an osmotic 
mini-pump (Alzet 2001). These minipumps were designed to 
deliver fluid at a constant rate with a nominal value of 0.9 
~l/hr for seven days. At the end of the first week the 
minipumps were replaced by new ones. 
Tail systolic blood pressure (SBP) was measured plethysmo-
graphically in conscious, acclimatized rats after prewarming 
for 20 minutes. The average of three consecutive SBP readings 
was taken as the daily blood pressure. 
Renal function 
Renal function was estimated by means of the glomerular 
filtration rate (GFR) and determined as the clearance of 51 
Cr-EDTA. This method allows for repeated measurements in the 
same animal and has been described in detail elsewhere (8). 
The GFR was measured one, three, and six weeks after 
transplantation or unilateral nephrectomy. 
Experimental P£Otoco1 
After determining control values of SBP, the rats 
receiving a kidney transplant (Tx) were divided into 10 groups 
with divergent immunosuppressive regimens (see Table 1) 
Three groups (Txl, Tx3, Tx5) received prednisolone alone in 
doses of 8, 4, or 2 mgjkg/day; five groups (Tx2, Tx4, Tx6, 
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TABLE 1 IMMUNOSUPPRESSIVE REGIMENS 
RECIPIENTS n/J'l'* PREDNISOLONE DSB CONTROLS n 
group Tx1 6/10 8 mgjkgjday no 
group Nx1 12 
group Tx2 5/10 8 mgjkgjday yes 
group Tx3 6/11 4 mg/kg/day no 
group Nx2 11 
group Tx4 5/9 4 mg/kgjday yes 
group Tx5 3/8 2 mgjkgjday no 
group Nx3 10 
group Tx6 5/6 2 mg/kg/day yes 
--------- 1 mg/kg/day no 
group Nx4 6 
group Tx7 7/10 1 mg/kgjday yes 
--------- 0.5 mg/kg/day no 
group Nx5 5 
group Tx8 6/7 0.5 mg/kg/day yes 
group Tx9 7/9 no yes 
group Nx6 10 
group Tx10 0/5 no no 
* number of rats starting ( N) and completing (n) the 
observation period. 
--------------------------------------------------------------
Tx7, Tx8) received DSB pretreatment in combination with 
prednisolone in doses of 8, 4, 2, 1, or 0.5 mgjkg/day; group 
Tx9 received only DSB pretreatment; and finally, group Tx10 
received no immunosuppressive treatment at all. 
These 10 groups of recipient rats were compared with six 
groups of unilaterally nephrectomized control rats (Nx), also 
listed on Table 1. The original plan called for the inclusion 
of control groups with or without DSB pretreatment. Half of 
all control rats received pretreatment with DSB. As DSB had 
no significant effect on the blood pressure of the Nx rats, 
the pretreatment was 
unilateral nephrectomy, 
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subsequently disregarded. After 
the first five groups of control rats 
received prednisolone in doses of 8, 4, 2, 1 or 0.5 mgjkg/day. 
The last group (Nx6) had no prednisolone. 
Statistics 
Only transplant recipients with a survival of 6 weeks were 
included in the statistical analysis. Differences in means 
within the Tx or Nx groups were compared by a one-way 
analysis of the variance. In case of significant differences 
(p<0.05), the Newman-Keuls test was used to find which pairs 
of means were different (9). 
RESULTS 
Prednisolone in combination ~ith DS~ 
The results for the recipient rats who received DSB 
pretreatment are given in figure 1. Recipient rats who 
received DSB pretreatment alone (Tx9) showed the expected rise 
in blood pressure in the second week after allogeneic kidney 
transplantation. These rats remained hypertensive till the end 
of the observation period. The allografted rats who received 
DSB in combination with the higher doses of prednisolone (8, 
4, or even 2 mgjkg/day for 2 weeks) showed a similar rise in 
blood pressure. However, upon cessation of the prednisolone 
infusion, the rats in these groups (Tx2, Tx4, Tx6) became 
normotensive with blood pressure levels significantly below 
those of the Tx9 group who received DSB alone (p<0.05). 
SBP 
(mm Hg) 
180 
170 
160 
150 
140 
130 
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* 120L(--~~--~--~----~--~--~~~~~~~------
Tx 2 3 4 5 6 
TIME (weeks) 
Figure 1: SBP of allogeneic kidney transplant recipients 
pretreated with DSB and infused continuously with 
divergent doses of prednisolone. Bar ihdicates 
duration of infusion in weeks. Means ± SEM are 
given. *p<0.05 compared with recipient rats 
receiving DSB only. 
o: Tx2, n=S A: Tx7, n=7 
A: Tx4, n=S II: Tx8, n=6 
[]; Tx6, n=S e: Tx9, n=7 
For specification of groups see Table 1. 
66 
SBP 
(mmHg) 
180 
170 
160 
* 
150 
140 
130 
120 
-
[ 
Nx 2 3 4 5 6 
TIME (weeks) 
Figure 2: SBP of unilaterally nephrectomized control rats 
continuously infused with divergent doses of 
prednisolone. Bar indicates duration of infusion. 
*p<0.05 compared with Nx rats receiving no 
prednisolone. 
0: Nxl, n=12 .A: Nx4, n=6 
A: NX2, n=ll 
·= Nx5, n=5 
c: Nx3, n=lO •= Nx6, n=lO 
For specification of groups see Table 1. 
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No hypertension was found at all in group Tx7 (1 mg/kg/day 
prednisolone+ DSB). Throughout the study, the blood pressure 
of these rats remained significantly lower than that of the 
Tx9 rats who received DSB alone (p<0.05). Group Tx8 (0.5 
mg/kg/day predni~olone + DSB) had a slightly but not 
significantly lower SBP than group Tx9. 
Figure 2 gives the results for the six groups of Nx rats. 
The three groups that received prednsiolone in doses of 
2mg/kg/day or more showed a rise in blood pressure. However, 6 
weeks after the unilateral nephrectomy, all differences 
between the groups had disappeared regardless of dosage. At 
that stage all control rats had become normotensive. 
The results for the GFR measurements are given in Table 2. 
When compared with Tx rats pretreated with DSB only, infusion 
with 4 or 8 mg/kg/day of prednisolone resulted in an increase 
of the GFR with about 50%. Infusion of 2 or 1 mg/kg/day had 
little effect on the GFR, but Tx rats infused with 0.5 
mg/kg/day showed a decrease of the GFR. After discontinuation 
of the prednisolone infusion, the differences in GFR between 
the various Tx groups disappeared. A similar effect was noted 
in the prednisolone infused Nx rats. 
Figure 3 gives the SBP of allograft recipients that did 
not receive DSB pretreatment (Tx1, Tx3, Tx5, Tx10) and were 
either infused with diverse doses of prednisolone for two 
weeks or received no immunosuppressive treatment at all. 
SBP 
(mm Hg} 
180 
170 
160 
150 
130 
120[ -
Tx 2 
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>200 
I 
I 
3 4 5 6 
TIME (weeks) 
Figure 3: SBP of allogeneic kidney transplant recipients 
continuously infused with divergent doses of 
prednisolone. Bar indicates duration of infusion 
in weeks. Means ± SEM are given. 
o:Txl, n=6 
A:Tx3, n=6 
c:Tx5, n=8 
e:TxlO, n=5 
For specification of groups see Table 1. 
Table 2. 
GROUP 
Tx1 
Tx2 
Tx3 
Tx4 
Tx5 
Tx6 
Tx7 
Tx8 
Tx9 
Tx10 
Nxl 
Nx2 
Nx3 
Nx4 
Nx5 
Nx6 
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POSTOPERATIVE GLOMERULAR FILTRATION RATE OF 
ALLOGRAFTED AND UNILATERALLY NEPHRECTOMIZED RATS 
GLOMERULAR FILTRATION RATE 
ml/min/100 g body weight 
============================================ 
WEEK 1 WEEK 3 WEEK 6 
0.50±0.17 0. 30±0 .11 0.28±0.11 
0.51±0.10** 0.34±0.13 0.30±0.14 
0.36±0.19 0.30±0.10 0.23±0.12 
0.48±0.10 0.35±0.09 0.33±0.06 
0.13±0.10** (0.15±0.01)# (0.09±0.02)# 
0. 29±0 .11 0.25±0.04 0.25±0.06 
0. 28±0 .11 0.23±0.06 0.28±0.08 
0.18±0.07** o.20±o.oo 0.20±0.08 
0.31±0.11 0.29±0.10 0. 26±0 .11 
0.08±0.02** no survivors no survivors 
0.69.:!::0.08* 0.47.:!::0.16 0.49.:!::0.05 
0.64±0.07* 0.50.:!::0.06 0.48.:!::0.06 
0.59±0.04* 0.47.:!::0.04 0.45.:!::0.03 
0.49.:!::0.05 0.47.:!::0.05 0.42.:!::0.05 
0.44±0.06 0.46.:!::0.05 0.46.:!::0.06 
0.50.:!::0.07 0.50.:!::0.07 0.50.:!::0.04 
-------------------------------------------------------------
-------------------------------------------------------------
Data are mean ±s.d. 
* p<0.05 compared to unilaterally nephrectomized rats 
receiving no prednisolone (Nx6). 
** p<0.05 compared to recipient rats receiving DSB but no 
prednisolone (Tx9). 
Three out of eight rats.For specification of groups see 
table 1. 
Doses of 8 and 4 mg/kg/day caused a rise in blood pressure 
during the infusion period, while in these groups (Tx1, Tx3) 
the hypertension persisted after cessation of prednisolone 
infusion. The rats in these groups remained hypertensive 
throughout the follow-up period. The GFR of these two groups 
was almost identical to the clearance of allografted rats 
receiving the same dose of prednisolone in combination with 
DSB (see Table 2). Five of the eight rats in group Tx5 
receiving prednisolone alone in a dose of 2 mg/kg/day, died 
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within 7 days after cessation of the prednisolone infusion. 
The remaining three recipient rats treated with this low dose 
of prednisolone alone, survived for the remaining 4 weeks of 
the follow-up, albeit with a very high blood pressure. The 
GFR of these three rats was reduced and in the same low order 
as allografted rats receiving no immunosuppressive treatment 
at all. These rats (Tx10) all died within 11 days after 
transplantation. During 
normotensive until day 8, 
rise (see figure 3). 
this period the rats were 
from then on their SBP started to 
DISCUSSION 
The use of prednisolone effectively prolongs the survival 
of kidney and heart allografts in rats (10,11). We found that 
the administration of prednisolone by continuous infusion with 
subcutaneously implanted osmotic minipumps resulted in a 
prolongation of rat heart allograft survival enabling lower 
dosage than with daily injections (6). The present study 
revealed that continuous administration of prednisolone had a 
dosage-related effect on rat renal allograft survival. In the 
absence of adjuvant immunosuppressive therapy, the minimal 
dose of prednisolone required for an immunosuppressive effect 
was shown to be 2 mg/kgjday in continuous infusion. However, 
at the end of the two-week follow-up period, the function of 
these grafts was comparatively lower than that of recipient 
rats treated with Cyclosporin A for one week after allogeneic 
renal transplantation (3). In combination with DSB 
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pretreatment, a dose of only 1 mg/kg/day prednisolone for two 
weeks had a similar effect as Cyclosporin A. 
In agreement with other experimental studies in rats 
using methylprednisolone (12,13), our present study also 
revealed that prednisolone has a distinct dosage-related 
effect upon blood pressure. Several mechanisms have been 
suggested to explain the rise in blood pressure caused by 
glucocorticoids, such as a) metabolization of prednisone to 
aldosterone (14); b) increased activity of the renin-
angiotensin system, although elevated blood pressure levels 
were noted even during continuous captopril adminstration 
suggesting participation of other mechanisms (12); c) salt 
retention (15); or d) activation of the sympathetic nervous 
system (16). 
Various authors have reported that corticosteroids 
contributed to the development of hypertension after renal 
transplantation in man. One study (5) described a correlation 
between diastolic blood pressure and the dose of prednisone in 
a group of allograft recipients. These findings were not 
confirmed in other studies (17,18). It was reported, however, 
that a reduction in dosage of the corticosteroids or 
conversion to alternate-day therapy resulted in a fall in 
blood pressure (19,20). 
The results of our present study show that the 
hypertension observed in rat renal allograft 
treated with prednisolone 
mechanisms. Recipient rats 
may be due to 
treated with 
two 
2 
recipients 
different 
mg/kg/day 
prednisolone or more may develop high blood pressure due to a 
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direct action of steroids. This type of hypertension is 
reversible, as shown in the allograft recipients pretreated 
with DSB and receiving 2 mg/kg/day or more, as well as in the 
unilaterally nephrectomized rats. All these rats became 
normotensive after cessation of the prednisolone infusion. In 
some groups of recipient rats hypertension persisted after 
cessation of prednisolone infusion. These rats had either not 
been pretreated with DSB or if they had, prednisolone was 
administered in a very low dose (0.5 mgjkgjday). Such 
treatment obviously amounts to insufficient immunosuppression 
and consequently, to an incomplete prevention of rejection of 
the allograft. 
in this rat 
In comparison, we have previously found that 
development 
humans, the 
model the use of Cyclosporin A prevented 
of post-transplantation hypertension (3). 
chronic types of rejection processes are 
associated with a rise in blood pressure (17,21). 
the 
In 
also 
The administration of prednisolone in combination with DSB 
pretreatment as adjuvant immunosuppressive therapy led to 
allografted rats either becoming normotensive after cessation 
of the corticosteroid infusion or to them not developing 
hypertension at all. These findings illustrate the important 
role of the rejection processes in the development of 
hypertension as surmised in our previous experiment using DSB 
pretreatment as the only immunosuppressive procedure (1). 
In conclusion, the present experiment using prednisolone 
in rat renal allograft recipients, clearly shows the 
effectiveness of this drug. However, unless extreme care is 
taken to find the optimal dosage of prednisolone in 
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combination with adjuvant immunosuppression, there is always 
the inherent risk of hypertension. 
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Summary 
1. In an experimental model of post-renal 
transplantation hypertension in rats, we studied 
the effect of a reduction of sodium intake on the 
development of this type of hypertension. 
2. Systolic blood pressure,. plasma-renin con-
centration and renal function were measured 
regularly in recipients of an allogeneic kidney 
transplant that had previously undergone active 
immunological enhancement. 
3. Transplant recipients on a normal diet 
showed a rise in systolic blood pressure during the 
second week after transplantation. The systolic 
blood pressure of recipients on a low sodium diet 
remained normotensive throughout the 15 weeks 
follow-up period. 
4. The plasma renin concentration was low in 
the hypertensive recipients on a normal diet, as 
compared with unilaterally nephrectomized 
controls. Although the plasma renin concentration 
of recipients on a low sodium diet fell below that 
of unilaterally nephrectomized controls on a low 
sodium diet, it was higher than that of recipients 
on a normal diet. 
5. The renal function of transplant recipients 
was greatly reduced compared with that of control 
rats. The glomerular filtration rate was reduced to 
a greater extent than the effective renal plasma 
flow. 
Correspondence: Dr A. P. Provoost, Department 
of Paediatric Surgery, Laboratory for Surgery, 
Erasmus University Medical School, Postbox 
1738, 3000 DR Rotterdam, The Netherlands. 
6. In a separate experiment it was revealed that 
a similar reduction in the glomerular filtration rate 
of kidneys permanently damaged by temporary 
ischaemia did not result in an increase in the 
systolic blood pressure. 
7. Survival up to 6 weeks after transplantation 
was the same for both groups of recipients. Re-
cipients on a low sodium diet, however, showed a 
better 15 weeks survival, probably owing to the 
absence of hypertension in this group. 
8. The prevention of the development of 
hypertension by means of a reduction of sodium 
intake, points to an involvement of sodium re-
tention in this post-transplantation hypertension 
model. 
Key words: hypertension, kidney transplantation, 
plasma renin concentration, sodium intake. 
Introduction 
Hypertension after clinical renal transplantation is 
a relatively common medical complication [1]. It 
has been reported in a large percentage of adult 
[2] as well as paediatric transplant recipients [3]. 
This hypertension after renal transplantation is 
usually attributed to various factors [1]. Among 
these, the corticosteroid therapy, renal artery 
stenosis, the presence of the recipient's own 
diseased kidney, and acute or chronic rejection are 
most frequently mentioned. Investigation of the 
relevance of the individual hypertensive 
mechanisms in human renal transplantation is 
difficult, owing to the great variation of factors 
normally present. 
We have recently succeeded in developing an 
experimental model of post-renal transplantation 
hypertension [4]. This model consisted of an 
allogeneic kidney transplantation between normo-
tensive donor and recipient rats. The survival time 
of the recipients was prolonged by means of 
active immunological enhancement, avoiding the 
use of corticosteroids. It was noted that the 
hypertension was associated with a low plasma 
renin concentration. We surmized that the hyper-
tension and the low plasma renin concentration 
might be the result of sodium retention by the 
transplanted kidney. Consequently, we studied the 
effect of a reduction of sodium intake upon the 
blood pressure after allogeneic renal transplanta-
tion in rats. 
Methods 
Rats 
Adult male rats, circa 3 months of age with a 
body weight of 250-300 g, of highly inbred 
Wistar (WAG/Ro) and Brown Norway (BN) 
strains were used. These strains differ at the major 
histocompatibility locus. The WAG/Ro rats are 
RT-1 Y, the BN rats are RT-1 n [5]. 
Diets 
The rats had free access to food and water. 
Both normal food and sodium-poor diet were 
obtained from Hope Farms, Woerden, The Nether-
lands. The normal diet contained 120 mmol of 
Na/kg, the sodium-poor diet contained 5.6 mmol 
of Na/kg, and the drinking fluid (tap water) con-
tained 2.4 mmol of Na/1. Besides a difference in 
sodium content there was also a small difference 
in protein content: the normal diet contained 24% 
of protein, the sodium-poor diet contained 17-
18% of protein. 
From separate balance studies we know the 
food and water intake of transplant recipients on a 
normal diet. The intake is variable just after 
transplantation but stabilizes after a few weeks at 
about 6 g of food and 20 ml of water per day per 
100 g body weight. The calculated sodium intake 
then amounts to about 0.77 mmol day- 1 100 g- 1 
body weight. No data are at present available on 
the food in take of recipients on a sodium-poor 
diet. When the same amount is consumed, 
however, the daily sodium intake amounts to 
about 0.085 mmol/100 g body weight. In these 
rats the major part of the sodium intake stems 
from the drinking fluid. 
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Experimental procedure 
Comparison of a normal and a low sodium diet 
upon post-renal transplantation hypertension. Two 
groups of WAG/Ro transplant recipients and two 
groups of WAG/Ro unilaterally nephrectomized 
control rats were compared. The remaining 
kidneys of the previously unilaterally nephrecto-
mized BN rats were used as donor kidneys. The 
renal transplantation was performed with micro-
surgical techniques as described previously [4, 6]. 
The recipients underwent bilateral nephrectomy at 
the time of transplantation. Active immunological 
enhancement by means of a single intravenous in-
jection of 1 ml of BN rat blood to the recipient, 
2 weeks before transplantation, was carried out to 
prolong graft survival [4, 7]. Transplantations 
were considered technically successful when 
recipients survived for at least 1 week. 
One group, initially consisting of 17 successful 
allograft recipients, had free access to normal food 
and so did a group of four unilaterally nephrecto-
mized controls. A third group, initially consisting 
of 16 successful allograft recipients, had free 
access to a low sodium diet from the day of trans-
plantation. A group of six unilaterally nephrecto-
mized control rats also had a low sodium diet from 
the day of nephrectomy. 
In all four groups, systolic blood pressure, renal 
function and plasma renin concentration were 
measured regularly. The systolic blood pressure 
was measured six times a week from 1 week before, 
to 3 weeks after transplantation or nephrectomy. 
After 3 weeks the systolic blood pressure was 
measured every other day. The glomerular filtra-
tion rate and the effective renal plasma flow were 
measured 1 , 3, 6, 9 and 15 weeks after transplan-
tation or nephrectomy. At these times, 400 J.Ll 
of blood was sampled, 15 min after initiation of 
pentobarbital anaesthesia (60 mg/kg intraperito-
neally), to determine the plasma renin concentra-
tion and the plasma levels of creatinine and urea. 
At the end of the 15 week follow-up period, the 
glomeruli in the kidneys were counted. 
Effect of the presence of an intact native 
kidney. A group of five allograft recipients, 
surviving for at least 9 weeks, was studied. These 
recipients had one of their own kidneys removed 
at the time of transplantation, the second one 
being removed 3 weeks after transplantation. The 
rats received a normal diet. Systolic blood pressure 
and renal function were measured as in the 
previous experiment. At week 3 renal function was 
measured 2-3 h after nephrectomy. 
Effect of a reduction in function of non-trans-
planted kidneys. In a group of 10 WAG/Ro rats 
renal function was reduced by means of an 
induced temporary ischaemia. A clamp (Schwarz 
aneurysm clamp) was applied to the right renal 
artery for 105 min. After a recovery period of 1 
week, the contralateral kidney was removed. 
Systolic blood pressure was measured regularly, 
starting 1 week before the induced ischaemia. 
Renal function was measured 1, 3, 6 and 9 weeks 
after ischaemia. The measurement at week 1 was 
taken 2-3 h after nephrectomy. 
Measurements 
Systolic blood pressure. This was measured in 
conscious rats by tail plethysmography (Electro 
Sphygmo Manometer PE 300, Narco Bio-System). 
The animals were prewarmed at an environmental 
temperature of 32°C and to take their blood 
pressure were placed in small restraining cages. The 
daily systolic blood pressure was the average of at 
least three consecutive measurements. The systolic 
blood pressure data given in the Results section 
consist of the mean systolic blood pressure taken 
on 3 consecutive days. 
Glomerular filtration rate and effective renal 
plasma flow. These were measured, under pento-
barbital anaesthesia, as the plasma clearances of 
51Cr-labelled EDTA and P25I]iodohippurate re-
spectively. This method, which allows for repeated 
measurements in the same rat, has been described 
in detail elsewhere [6, 8]. 
Plasma creatinine, urea and renin concentra-
tions. These were determined in samples obtained 
during the measurements of renal function, before 
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the injection of the radioactive compounds. The 
samples were taken about 15 min after the intra· 
peritoneal injection of pentobarbital (60 mg/kg). 
Creatinine and urea were measured by kinetic 
methods on a computer directed analyser in 
50 pl and 10 ,ul of plasma respectively [9]. 
The plasma renin concentration was determined 
through the angiotensin I (ANG I) generated after 
incubation of 100 pl of plasma with an excess of 
rat renin substrate at pH 6.5 [10]. · 
Number of glomeruli. At the end of the 15 
week follow-up period, the remaining animals were 
killed just after the intra-arterial injection of 1 ml 
of India ink close to the renal artery. The kidney 
was removed, weighed and the glomeruli were 
counted by a modification [11] of the method of 
Damanian et al. [12]. 
Statistics 
All results are given as means ± sn. Comparison 
of the differences in mean values of the transplant 
recipients on a normal and a low sodium diet was 
done by Student's t-test. A difference was con-
sidered statistically significant when the prob-
ability level reached P< 0.05. 
Results 
Comparison of recipients on either a normal or a 
low sodium diet after allogeneic transplantation 
Systolic blood pressure. Systolic blood pressures 
of both groups of allograft recipients are depicted 
50 60 70 80 90 100 110 
Time (days) 
FIG. 1. Systolic blood pressures of renal allograft recipients on a normal (•) and a 
sodium-poor (O) diet. The cross-hatched area represents the normotensive systolic 
blood pressure of unilateral nephrectomized control rats. TX, Day of transplantation. 
in Fig. 1. In recipients on a normal diet the 
systolic blood pressure started to increase from 
day 8 after transplantation. From then on the 
systolic blood pressure remained elevated until the 
end of the 15 weeks follow-up period. 
In contrast, the systolic blood pressures of 
transplant recipients on a low sodium diet 
remained within the range of normotensive uni-
laterally nephrectomized control rats, except for a 
slight elevation around week 3 after transplanta-
tion. The systolic blood pressures of recipients on 
a low sodium diet were significantly lower than 
those of recipients on a normal diet from day 8 
onwards. 
Renal function. Renal function measurements 
made at various times after transplantation or uni-
lateral nephrectomy are given in Tables 1 and 2, 
together with data on body weight, systolic blood 
pressure and plasma renin concentration. Renal 
function results and the body weights of donor 
rats, and pre-operative data regarding body weight 
and systolic blood pressure of recipients, are also 
included. 
The glomerular filtration rate of transplanted 
kidneys in rats on a normal diet amounted to 
30-40% of that of nephrectomized rats on a 
normal diet. In general, the glomerular filtration 
rate of recipients on a low sodium diet was some-
what higher than that of recipients on a normal 
diet. The difference was statistically significant at 
weeks 3, 6 and 9. 
There was less divergence in the effective renal 
plasma flow of transplanted kidneys when rats on 
a normal diet were compared with those on a low 
sodium diet. In comparison with that of unilaterally 
nephrectomized control rats, the effective renal 
plasma flow of transplanted kidneys appeared 
less impaired than the glomerular filtration rate, 
leading to a fall in the glomerular filtration rate/ 
effective renal plasma flow ratio. 
Plasma renin concentration. The renin concen-
tration of plasma obtained under pentobarbital 
anaesthesia from transplant recipients on both 
diets was less than that of their respective controls. 
The plasma renin concentration in recipients on a 
normal diet remained at the same low level 
throughout the follow-up. In the recipients on a 
low sodium diet, the mean plasma renin concentra-
tion values were higher than those of recipients on 
a normal diet, but there was a tendency to 
decrease. Statistically, however, the difference was 
only significant at weeks 1 and 3. 
Wet kidney weight and number of glomeruli. 
The glomeruli of non-transplanted BN kidneys 
were counted in a separate group of unilaterally 
nephrectomized BN rats. In nine rats with a body 
weight of 399 ± 25 g, the wet kidney weight 15 
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weeks after unilateral nephrectomy amounted 
to 436± 59 mg/100 g body weight and the number 
of glomeruli was 31 240 ±4765. 
The glomerular counting of transplanted BN rat 
kidneys at the end of the follow-up period showed 
a reduction in the number of glomeruli. Trans-
planted kidneys from recipients on a normal diet 
(n = 5) weighed 654 ± 123 mg/1 00 g body weight 
and contained 21 089 ±4297 glomeruli. The wet 
kidney weight of transplanted kidneys from 
recipients on a sodium-poor diet (n = 11) was 
515 ±45 mg/100 g body weight and the kidneys 
contained 26 911 ± 3164 glomeruli. The difference 
between the wet kidney weights as well as the 
numbers of glomeruli were significant when 
recipients on a normal diet were compared with 
those on a sodium-poor diet (P<0.05). 
Kidneys from unilaterally nephrectomized 
WAG rats on either a normal or a low sodium diet 
contained 35 350 ±4174 (n =4) and 34 512 ± 
5322 (n = 5) glomeruli respectively. 
Survival. The sodium-poor diet after transplanta-
tion had a marked effect on the survival of the 
recipients. As depicted in Fig. 2, both groups had 
a mortality of 30% between week 1 and week 3. 
After the week 3 only recipients on a normal diet 
died. This resulted in a 15 week survival of 30% 
of the recipients on a normal diet and 70% of the 
recipients on a sodium-poor diet. 
Effect of the presence of an intact kidney 
The systolic blood pressure of transplanted 
recipients on a normal diet with one native kidney 
still in situ remained at a normal level till the end 
of week 3. After the removal of the native kidney 
the systolic blood pressure increased. Just before 
removal of the native kidney, the mean systolic 
blood pressure was 114± 11 mmHg, and was 
159 ± 23 mmHg 3 weeks later. 
Directly upon the removal of the native kidney 
of the transplanted rats, the function of the 
transplanted kidney was very low. The glomerular 
filtration rate and effective renal plasma flow 
gradually improved and 6 weeks after nephrec-
tomy they both reached values comparable with 
those of kidneys of transplanted rats on a normal 
diet, The glomerular filtration rate was 0.77 ± 
0.33 ml/min and the effective renal plasma flow 
was 3.90 ± 0.70 ml/min. 
Effect of a reduction in renal function 
Renal function results and systolic blood 
pressures of rats that underwent temporary 
clamping of the renal artery are given in Table 3. 
The glomerular flltration rate and effective renal 
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FIG. 2. Mortality of renal allograft recipients on a normal (--) and a sodium-poor 
diet (---). Surviving rats were killed 15 weeks after transplantation. For rats on a 
normal diet 100% = 1 7; for rats on a sodium-poor diet 100% = 16. 
TABLE 3. Renal function parameters and systolic blood pressure of rats with a renal 
artery temporarily clamped, and contralateral nephrectomy after 1 week 
All data are means± SD. Abbreviations are defined in Table 1. 
Week 1 
No. ofrats 10 
Body wt. (g) 250±9 
SBP(mmHg) 112±8 
GFR (ml/min) 0.32 ± 0.09 
ERPF (ml/min) 1.36±0.39 
GFR/ERPF 0.24 ±0.04 
Per (.umol/1) 207 ±40 
Pur (mmol/1) 31.9 ±5.8 
plasma flow of the damaged kidneys were similar 
to or lower than those of transplanted rats on a 
normal diet. In spite of their diminished renal 
function these rats remained normotensive 
throughout the 9 weeks follow-up period. 
Discussion 
The present findings confirm the previously re-
ported elevation in blood pressure after allogenic 
kidney transplantation in actively enhanced 
recipients [ 4 ]. The hypertension persisted during a 
follow-up period of 15 weeks. The experiments 
demonstrated that hypertension after renal trans-
plantation in rats can be prevented by a reduction 
of the sodium intake. The normal blood pressure 
Post-nephrectomy 
Week 3 Week6 Week 9 
8 7 6 
271 ±10 277 ±11 285 ±9 
120±5 130±8 128 ±9 
0.42 ±0.14 0.38 ±0.22 0.40±0.21 
1.82 ± 0.48 1.88 ±0.69 1.96 ±0.80 
0.23 ±0.02 0.19 ±0.06 0.20 ±0.03 
128±21 112 ±23 127 ±24 
23.6 ±4.1 23.6 ±4.5 27.5 ±5.0 
range in these rats significantly increased survival 
at the end of a 15 weeks follow-up period. 
There are other models of experimental hyper-
tension in rats in which only one kidney is present. 
Of these models renovascular, one-kidney, one-clip 
(lKl C) hypertension is the one most investigated. 
lKl C hypertension is associated with an increase 
in extracellular volume and exchangeable sodium 
and a low or normal plasma renin activity [13-16]. 
According to the criteria of the vasoconstrictor-
volume concept, the hypertension in the lKl C 
model is considered to be volume-dependent [17, 
18]. 
Our model of post-renal transplantation hyper-
tension, however, is different from the renovascu-
lar lKlC type. A reduction of the dietary intake 
of sodium alone, which in our model prevented 
the post-transplant hypertension, does not depress 
the systolic blood pressure in the 1K1 C rats. In 
those rats the hypertension becomes renin-depen-
dent [14, 19-22], and only extreme sodium and 
volume depletion reduce the systolic blood 
pressure [23]. 
If renovascular alterations at the transplanted 
kidney were of importance, renal transplantation 
with one native kidney still in situ should resemble 
the two-kidney, one-clip hypertension model. 
However, in our experiment no hypertension was 
observed. Our findings indicate that the observed 
hypertension does not have a renovascular origin. 
Consequently, the transplanted kidney itself 
should be considered of primary importance in 
the development of this type of hypertension. 
Despite the divergence from the lKlC model, 
we consider that sodium retention is involved in 
the hypertension after allogeneic kidney trans-
plantation. However, in contrast to the Goldblatt 
models, where the cause of sodium retention lies 
outside the kidney, i.e. the stenotic artery, we 
think that in post-transplant hypertension sodium 
retention is primarily a renal process. 
Although active immunological enhancement 
does prolong the survival time of rats after renal 
transplantation, it does not completely suppress 
rejection. Consequently, damage of the trans-
planted kidney, due to immunological reactions, 
is present. This was not only shown by histo-
pathology [4], but is also indicated by the 
impairment of the glomerular filtration rate and 
by the number of deaths occurring between days 7 
and 21 after transplantation. The renal functional 
impairment of the allogeneic recipients resembles 
the picture of acute experimental glomerulo-
nephritis. secondary to immunological reactions 
[24, 25]. In acute experimental glomeruloneph-
ritis in rats, changes in renal function similar to 
those in allografted kidneys, i.e. a greater impair-
ment of the glomerular filtration rate than of the 
effective renal plasma flow, together with sodium 
retention and suppression of the renin se~retion, 
was noted. 
Rats with an allogeneic transplanted kidney 
together with one intact native kidney in situ did 
not develop hypertension. In this case the de-
creased sodium excretion by the allografted 
kidney is probably adequately compensated for 
by the native kidney at a normal blood pressure. 
Once the native kidney is removed, the kidney 
graft apparently cannot handle the sodium 
excretion and a volume-dependent hypertension 
will develop owing to sodium accumulation. 
The plasma renin concentration was measured 
in plasma obtained after 15 min of pentobarbital 
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anaesthesia, which is known to stimulate renin 
release [26]. The low plasma renin concentration 
values, found in both hypertensive and normo-
tensive recipients, must therefore indicate that the 
renin-angiotensin system is not involved in the 
development of post-transplant hypertension. In-
stead, the low plasma renin concentration values 
indicate sodium and water retention, as postulated 
before, whereas the higher plasma renin concen-
tration values in recipients on a low sodium diet 
suggest that the extent of sodium retention is less 
than in recipients on a normal diet. 
It can be argued that the observed hypertension 
might be the result of the impaired renal function 
alone. However, rats with a diminished renal 
function, due to temporary clamping of the renal 
artery, did not develop hypertension at all, 
although their kidney function was the same or 
worse than that of transplanted rats on a normal 
diet. This finding is in agreement with those re-
ported by other investigators [2 7]. Consequently, 
an impaired renal function as such did not cause 
hypertension in our model. 
The low sodium diet may have had better 
immunosuppressive properties than the normal 
diet. However, the mortality between day 7 and 
day 21 is the same for the transplanted rats on 
either diet. ln both groups about 30-35% of the 
rats died during this period. This may indicate a 
similarity of the immunological rejection process 
in this period. In transplanted rats on a sodium-
poor diet no rats succumbed after day 21, 
probably due to the prevention of hypertension. 
The sodium-poor diet contained less protein 
than the normal diet. It has been shown, in rats 
with a moderate renal insufficiency, that daily 
protein intake influences the deterioration rate of 
renal function as well as survival [28]. A difference 
in daily protein . intake between transplant 
recipients on either a normal or a sodium-poor 
diet could also have had a different effect on renal 
function and survival rate. However, the difference 
in the protein content of both diets is relatively 
small, especially when compared with other 
studies relating protein intake and the progression 
of renal disease [27, 28]. Consequently, we assume 
that the changes induced during the first 3 weeks 
after transplantation are of major importance in 
explaining the present findings. 
In conclusion, the increase in systolic blood 
pressure after allogeneic renal transplantation in 
immunologically enhanced recipients was 
prevented by reducing the daily sodium intake. 
The hypertension was not caused by the reduced 
renal function as such. These findings indicate that 
sodium is involved in this model of hypertension 
after renal transplantation in rats. 
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SUMMARY 
This study was undertaken to establish the relative 
significance of alterations in renal function and sodium and 
water intake and output during the development of hypertension 
after allogeneic kidney transplantation in our rat model. In 
this model the graft survival of the recipient rats was 
prolonged by pretreatment with donor strain blood. An inverse 
correlation between blood pressure and renal function of the 
recipient rats was noted 3 and 6 weeks after transplantation. 
Sodium was retained during the rise in blood pressure and 
excreted once the hypertension was established. Furthermore, 
polydipsia and polyuria developed after transplantation and 
more water was retained. Urinary osmolality was markedly 
decreased after transplantation and calciuria and proteinuria 
were present. The plasma volume of the recipient rats was 
significantly elevated when compared with unilaterally 
nephrectomized control rats. 
These results substantiate our hypothesis that in this rat 
model post-transplantation hypertension is mediated by a 
different water and sodium handling as a result of functional 
alterations in the allografted kidney. 
INTRODUCTION 
Post-transplantation hypertension is a frequent 
complication of human kidney transplantation occuring in about 
50 % of the recipients (1,2). Several hypotheses have been 
reported to explain this phenomenon. These involve the use of 
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corticosteroids (3), the presence of the recipients' own 
diseased kidneys (4) and rejection (5). 
We have developed a model to study post-transplantation 
hypertension in the rat using two normotensive rat strains. 
The survival of the allograft was prolonged by pretreatment of 
the recipient rats with donor strain blood. In this model the 
blood pressure of the recipient rats started to rise at the 
end of the first week after transplantation. The function of 
the transplanted kidney was markedly impaired and although the 
rats were hypertensive, the plasma renin concentration was 
suppressed (6). A later study confirmed these results and 
showed that the hypertension could be prevented by a reduction 
in the sodium intake (7). Further experiments showed that the 
development of hypertension could also be prevented by 
improving the immunosuppressive therapy by the use of 
cyclosporin A (8). From our experimental data we surmized 
that the development of hypertension was the result of 
structural and functional changes in the allografted kidney 
causing sodium retention and volume expansion, which are both 
known to be the mediators in the development of hypertension. 
In the present study we evaluated the relation between changes 
in renal function and blood pressure. We also carried out 
metabolic studies to determine the water and sodium balance. 
Finally, plasma volumes were measured at several intervals 
after allogeneic kidney transplantation. 
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MATERIALS AND METHODS 
General: adult male rats of the inbred Wag/Ro and BN/Ro 
strains, weighing 250 - 300 gram, were used. The rats had free 
access to food (Rat chow AM II, Hope Farms, the Netherlands) 
containing 120 meq sodium per kilogram and to tap water (3 meq 
sodium per litre). Transplantation of the BN donor kidney was 
performed using a method described previously (6). To prolong 
graft survival the Wag/Ro recipient rats were pretreated with 
1 ml of donor strain blood intravenously 2 weeks before 
transplantation. 
First experiment: this consisted of a retrospective 
analysis of data concerning 27 allograft recipient rats who 
survived for at least 6 weeks and who were included in several 
other studies. In this case we studied the correlation between 
the systolic blood 
filtration rate (GFR). 
pressure (SBP) and the glomerular 
The SBP was obtained from trained and 
conscious rats by means of the tail cuff method, using a 
sphygmomanometer (Narco Bio Systems, Houston, USA). The GFR 
was determined 1, 3, and 6 weeks after transplantation as the 
clearance of 51 Cr-EDTA. This method has been published in 
detail elsewhere (9). 
Second experiment: 21 Wag/Ro rats were placed in metabolic 
cages (Techniplast). Body weight (BW), water and food intake 
and urine volume were measured daily between 10 and 11 a.m. 
After 2 - 8 days of adaptat'ion, control values were 
determined. Then 12 rats received a kidney allograft and 9 
control rats were unilaterally nephrectomized. These two 
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groups were followed for 6 weeks. Urinary sodium was measured 
by flame photometry (Klina Flame, Beckmann) using lithium as 
internal standard. Calcium was measured colorimetrically 
(Rapid Stat Kit, Pierce Chemical Company) and the osmolality 
of the urine was determined by its freezing point (Vogel micro 
Osmometer, Roebling). Urinary protein was measured 
colorimetrically (Bio Rad Laboratories). 
Third experiment: the plasma volumes of a group of 7 
allografted Wag/Ro rats were compared with the plasma volumes 
of 7 unilaterally nephrectomized control rats. Plasma volumes 
were determined 1, 2, 3, and 6 weeks post-operative in ether 
anaesthetized animals using Evans Blue solution. Via the penis 
vein 0.2 ml Evans Blue solution (2 mg/ml) per 100 gram BW was 
injected slowly. After 5 minutes equilibration time a blood 
sample was drawn from the eye plexus. The extinction of the 
plasma was measured at a wavelength of 600 nm. The haematocrit 
(Ht) was determined after centrifugation of a blood sample 
taken in a capillary tube. The plasma volume (PV) and blood 
volume (BV) were calculated from standard formulas. 
Statistics: in the first experiment the relationship 
between the GFR and the SBP was calculated by linear 
regression. To evaluate the differences between the 
transplanted and the control group, the unpaired t-test was 
used in the other two experiments. 
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Systolic blood pressure of allograft recipient rats 
pretreated with donor strain blood. Shaded area 
represents the normotensive blood pressure range of 
the recipient rat strain. Data are shown as means±SEM 
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Fig 2. The systolic blood pressure as a function of the GFR at 
week 3 (o) and week 6 (e). 
SBP=190-45xGFR, r=-o.44; p<O.OOl. 
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RESULTS 
First experiment: the mean SBP of the 27 recipient rats is 
shown in fig. 1 with the shaded area representing the 
normotensive SBP range. The SBP started to increase by the end 
of the first week after transplantation and was significantly 
elevated from day 8 till the end of the 6 week follow-up 
period. Fig. 2 shows the correlation between the GFR and the 
SBP at week 3 and 6. There was a weak relationship between 
both parameters (r = -0.44), which was significant (p<0.001). 
No correlation was found between the GFR and the SBP one week 
after transplantation. 
Second experiment: seven of the 12 recipient rats survived 
for more than 6 weeks and were included in this study. Fig. 3 
and 4 depict the urinary calcium and protein excretion. The 
excretion of protein and calcium started to rise in the first 
week after transplantation and remained elevated throughout 
the study (p<0.05 versus control group). In the unilaterally 
nephrectomized group no differences in calcium or protein 
excretion were noted after nephrectomy compared to pre-
operative values. In fig. 5 urinary osmolality is given. 
Unilateral nephrectomy resulted in a significant decrease in 
urinary osmolality (p<0.05, paired data), while the osmolality 
of the allografted recipients was further reduced (p<0.05 
versus control group). Water turnover in the recipient rats 
was markedly elevated (fig. 6) as water intake and urine 
volume were both increased after the insertion of an allograft 
(p<0.05 versus control group). 
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Fig 3. Urinary calcium excretion before and after allogeneic 
kidney transplantation (o--o) or unilateral 
nephrectomy (e--e). Data are shown as means±SEM. 
*P <0.05 compared to unilaterally nephrectomized rats. 
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Fig 4. Urinary protein excretion before and after allogeneic 
kidney tr~nsplantation (o--o) or unilateral 
nephrectomy (e--e). Data are shown as means±SEM. 
*P <0.05 compared to unilaterally nephrectomized rats. 
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Fig 5. Urinary osmolality before and after allogeneic kidney 
transplantation (o--o) or unilateral nephrectomy (e--e) 
Data are shown as means±SEM. 
*P <0.05 compared to unilaterally nephrectomized rats. 
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Fig 6. Water intake (broken lines) and urinary volume (solid 
lines) before and after allogeneic kidney 
transplantation (o) or unilateral nephrectomy (e). 
Data are means ±SEM. 
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Fig. 7 gives the sodium intake and output of the allografted 
recipient rats and the unilaterally nephrectomized control 
rats. The transplantation or nephrectomy resulted in a fall in 
sodium intake and output in both groups. In the control group 
the balance between intake and output is restored within 3 
days. The sodium intake and output in the recipient rats show 
a disbalance in the first 10 days. After this period intake 
and output are at a higher level compared to pre-ope=ative 
values. 
Third experiment: the plasma volume of the recipient rats 
of an allogeneic kidney was significantly higher (p<0.05) than 
that of unilaterally nephrectomized rats throughout the 
follow-up period of 6 weeks (table 1). During this time, 
however, the haematocrit was markedly decreased (p<0.05 versus 
control group). Consequently, the two groups did not differ in 
blood volume per 100 g BW except at week 6, when the blood 
volume of the unilaterally nephrectomized rats was somewhat 
less than that of the allograft recipients. 
DISCUSSION 
The results of the present study indicate that in our 
model of post-transplantation hypertension the rise in blood 
pressure was associated with marked alterations in renal 
function. We found a weak, but significant, inverse 
correlation between the SBP and the GFR at 3 and 6 weeks after 
transplantation. We previously showed that a low GFR in itself 
did not produce hypertension (7). However, in the present 
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analysis a more severe reduction in GFR points to a more 
severe rejection reaction. Consequently the present analysis 
points to an association of the degree of rejection with the 
level of SBP after transplantation. 
Fig 7. 
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Sodium intake (broken lines) and urinary sodium 
excretion (solid lines) before and after allogeneic 
kidney transplantation (o) or unilateral nephrectomy 
(e). Data are means±SEM. 
The metabolic experiments showed that in rats allogeneic 
transplantation led to polyuria, proteinuria and a different 
handling of sodium and water by the allograft. Analysis of the 
latter revealed that transplanting a renal allograft initially 
resulted in a diminished excretion of sodium for 8 to 10 days. 
The retention of sodium was accompanied by an increased 
difference between water intake and urinary output. However, 
the exact measurement of water retention is very difficult 
because some factors involved are hard to measure: extra renal 
water loss, metabolic water and water retention due to growth. 
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Table 1. Body weight (BW), haematocrit (Ht), plasma volume 
(PV) and blood volume (BV) of allografted recipient 
rats (Tx) and unilaterally nephrectomized rats (Nx). 
PRE-OPERATIVE 
Nx(7) 
BW (gram) 279:!:.10 
Ht ( %) 48:!:.1 
PV (ml/100g) 4.7:t0.4 
BV (ml/100g) 9.0:!:.0.9 
WEEK 1 WEEK 2 
Nx Tx Nx 
270:!:.11 254:!:.13 * 273:!:.13 
45:!:.2 35:!:.3 * 43:!:.3 
5.4:!:.0.4 5.9:t0.6 5.3:!:.0.3 
9.8:!:.0.9 9. 1:!:.1. 1 9.4:!:.0.6 
WEEK 3 WEEK 6 
Nx Tx Nx 
282:!:.19 256:!:.19 * 296:!:.9 
44:!:.3 35:!:.5 * 46:!:.3 
5.1:!:.0.6 6.4:t0.7 * 4.5:t0.4 
9. 1:!:.1. 2 9.9:t0.8 8.4:t0.8 
Values are means±SD; number of rats in brackets. 
*P <0.05 compared with Nx. 
Tx(7) 
269:!:.13 
47:!:.2 
4.8:!:.0.3 
9.0:!:.0.8 
Tx 
247:!:.23 * 
38:!:.3 * 
6. 2:!:.1. 0 * 
9. 9:!:.1. 4 
Tx 
278:!:.16 * 
42:!:.2 * 
5.6:!:.0.6 * 
9.7:!:.0.5 * 
As a result of the diminished excretion of water and sodium 
the plasma volume of the recipient rats was increased. After 
the initial period in which the blood pressure started to 
rise, the blood pressure remained more or less stable. In this 
phase the excretion of sodium increased to a level higher than 
the values observed before transplantation, while in the 
recipient rats the increase in plasma volume persisted. The 
reason for the heightened rate of urinary calcium excretion is 
unknown, although it is reported that in response to expansion 
of the extracellular space the urinary calcium excretion is 
increased (10). 
Appearance of protein in the urine preceeded the 
establishment of hypertension, suggesting that nephritis-like 
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changes led to hypertension in our model. As we have 
demonstrated in previous studies (6,8) this malfunction of the 
allograft is due to an incomplete suppression of the 
rejection. Donor strain blood administration prior to 
transplantation prolonged the graft survival, but marked 
functional and structural changes were noted in the allograft. 
An increase in renin secretion is suggested as a common factor 
in hypertension associated with certain forms of renal 
malfunction, but in our model increased secretion of renin 
seems less likely to have caused the high blood pressure as 
plasma renin concentration levels were low. This study has 
supplied an explanation for the suppressed renin activity. It 
is well-known that renin concentration is reduced during high 
sodium intake or after sodium retention. Our metabolic studies 
suggested that sodium retention occurs after allogeneic kidney 
transplantation in the rat. 
Sodium retention in post transplantation hypertension in 
man has been described in some papers but most authors found 
no changes in exchangeable sodium or postulated that the 
retention was caused by a mineralocorticoid excess due to the 
conversion of prednisone to aldosterone (11). In one study 
(12) the amount of exchangeable sodium was measured in 
patients before and after renal transplantation. In the 
hypertensive recipients exchangeable sodium was increased 
significantly in contrast to an insignificant decrease in the 
normotensive recipients, while corticosteroid dosage was 
similar in both groups. The change in exchangeable sodium was 
also positively correlated to the mean blood pressure after 
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renal transplantation. These results were confirmed by another 
study carried out during the first weeks after kidney 
transplantation (13). 
The reason for sodium retention after renal 
transplantation is most probably intrinsic to the allografted 
kidney. As shown before (6) the GFR of the allograft was 
impaired to a greater extent than the effective renal plasma 
flow (ERPF), leading to a fall in the filtration fraction 
(ratio GFR : ERPF). This impaired renal function reflects the 
immunological processes present in the allografted kidney 
after donor strain blood pretreatment of the recipient. The 
rejection induces glomerular injury with relative preservation 
of tubular function, similar to that found in acute 
glomerulonephritis (14), where the total surface available for 
filtration is reduced. This is due to loss of functional renal 
mass as whole glomeruli are destroyed and also to functional 
nephrons being served by glomeruli with occluded capillaries. 
Another possible explanation for the sodium retention in 
allograft recipients is an altered renal tubular handling of 
sodium in the kidney transplant. 
The mechanism whereby sodium retention may lead to 
hypertension in kidney transplant recipients remains unknown. 
However, a close relationship between sodium and water balance 
and blood pressure regulation has been described in end-stage 
renal disease (15). In this context the view of Guyton and 
coworkers (16) is of importance. According to their hypothesis, 
the regulation of body fluid volume and sodium content is not 
related to the total renal mass, but to the balance between 
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glomerular filtration and tubular reabsorption. Very minute 
disorders in glomerular filtration capacity or tubular 
reabsorption capacity can lead to extreme changes in body 
water and sodium content. When the body water and sodium 
content becomes enhanced, the blood pressure rises to a level 
where the balance is restored. At that level sufficient 
amounts of water and sodium can be excreted. This is probably 
the reason for the correlation between renal function and 
blood pressure. Other possibilities involve sodium and water 
accumulation in the vessel walls, thereby compressing the 
lumen (17) or an increase of the vascular sensitivity for 
pressor substances, due to the positive sodium balance (18). 
In conclusion, our model of hypertension after kidney 
transplantation resembles the models of experimental 
glomerulonephritis, also characterized by proteinuria, 
reduction in GFR and suppression of the renin secretion. Due 
to an imbalance between glomerular filtration and tubular 
reabsorption, caused by the moderate rejection, water and 
sodium are retained, leading to a rise in extra cellular 
volume. Therefore, the observed hypertension is volume 
dependent and can be managed with an improvement of the 
immunosuppression or by a lower sodium intake. 
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GENERAL DISCUSSION AND CONCLUSIONS 
8.1 RATIONALE OF THE STUDY 
Patients with kidney transplants are often hypertensive and 
investigators have described the characteristics of this 
hypertension in man. Moreover, the hypertension of kidney 
transplant recipients is more likely to result in surgical 
intervention than hypertension in the general population. 
Even so the mechanisms of the many varieties of post-
transplantation hypertension are not completely known and 
studies, at best carried out in animal models, are rare. 
However, several animal studies have been performed that were 
designed to look at the pathophysiology of post-
transplantation hypertension. The renal cross-transplantation 
experiments of Dahl and Heine (1975) are the best known 
experimental studies of hypertension after transplantation, 
yet these were not designed to look at post-transplantation 
hypertension as such. Me Dougall et al. (1981) have used sheep 
to develop a model of renal transplantation hypertension in 
which the vascular supply to the transplanted kidney in the 
animal can easily be contricted to mimic transplant artery 
stenosis. 
Our aim was to develop a model of post-transplantation 
hypertension in rats in which the clinical problems of renal 
transplantation, such as rejection and immunsuppression, could 
be investigated. 
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8.2 MEASUREMENT OF RENAL FUNCTION 
As a parameter of renal function the glomerular filtration 
rate (GFR) was measured in the recipient rats and the control 
rats. Conventional methods to measure the GFR in rats require 
extensive surgery, a constant infusion and a increased urine 
production for accurate urine collection. All these procedures 
may influence the GFR measurement apart from being time 
consuming. In our series of experiments, we measured the GFR 
without urine collection using 51 Cr-EDTA and a single timed 
blood sample (Layzell and Miller, 1975) together with a 
formula to calculate the clearance rate (Bryan et al., 1972). 
This method has the advantage of enabling measurement in large 
number of rats at one and the same time, while it allows for 
repeat measurements in the same rats at different intervals. 
Although inulin remains the reference substance to measure 
the GFR, studies have ascertained the suitibility of 51 Cr-
EDTA (Chantler et al., 1969). In clinical practice 51 Cr-EDTA 
has been accepted and is widely used as a compound to measure 
the GFR (Ditzel et al., 1972; Brochner-Mortensen and Rodbro, 
1976). In contrast with inulin infusion for the determination 
of the GFR, the single injection technique can be used in 
adult as well as young rats. In adult rats, ~ good correlation 
was found between the filtration rates calculated by the 
present method and by other methods to establish the clearance 
(Bryan et al., 1972; Layzell and Miller, 1975; Provoost and 
Molenaar, 1980). In young rats, validation of the method we 
used with conventional measurements is technically almost 
impossible. Comparing our findings with data reported in the 
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literature showed the usefullness of the single injection 
technique (Aperia and Herin, 
Horster and Lewy, 1970). 
1975; Bengele and Solomon, 1974; 
In our experiments a single injection of 51 Cr-EDTA with a 
single plasma sample obtained after one hour, proved to be a 
very suitable method to determine the GFR in adult as well as 
young rats. 
8.3 ISOGENEIC KIDNEY TRANSPLANTATION (chapter 2) 
For the isogeneic kidney transplantation model, we used 
rats of a highly inbred strain. The genetic homogeneity of 
this strain has been confirmed by the permanent survival of 
intrastrain skin, heart and kidney grafts. In this setting, 
kidney damage caused by rejection is circumvented and, with 
donor and recipient rats of equal size, renal function of the 
transplanted kidney will only be influenced by damage caused 
by the transplantation procedure including storage as well as 
vascular and ureteral complications. Renal function may 
improve as the result of compensatory hyperfunction of the 
single grafted kidney. With donor and recipient of unequal 
size, post-transplantation renal function may likewise be 
influenced by the difference in size. From our studies it 
appears that the size of the recipient plays an important role 
in the functional outcome after renal transplantation 
(Provoost et al., 1984). The transplanted kidney behaves like 
a single organ pertaining to the recipient. 
Hypertension was not found in rats with isogeneically 
106 
transplanted kidneys, even when donor and recipient rat were 
different in size. This indicates that neither the presence of 
a kidney transplant as such nor differences in the ratio 
bodyweight/kidneyweight between donor and recipient will lead 
to a rise in blood pressure after transplantation. Therefore, 
other factors such as rejection and/or immunosuppressive 
therapy may cause the elevation of blood after renal 
transplantation in rats. 
8.4 ALLOGENEIC KIDNEY TRANSPLANTATION WITH DONOR STRAIN 
BLOOD PRETREATMENT OF THE RECIPIENT RATS (chap. 3) 
In the allogeneic kidney transplantation model, the 
recipient rats were from the same strain as those used in the 
isogeneic model. The donor kidneys were from Brown Norway rats 
and in this setting kidney grafts would be rejected within two 
weeks. To prolong graft survival, preimmunization with donor 
strain blood was used. Preimmunization has been commonly 
defined as the delay or inhibition of an immune response to 
specific antigens by antibodies directed against those 
antigens (Marquet, 1978). The antibodies may be produced by 
active preimmunization and are generated by the injection of 
antigens. The antigens may be presented to the host by 
injection of viable cells, lyophilized tissue, tissue extracts 
or by injection of serum proteins. Passive preimmunization by 
the injection of donor-specific antisera may also lead to 
prolonged graft survival. 
In the allogeneic kidney transplantation model the systolic 
blood pressure of the recipients started to rise in the second 
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week after transplantation. With active immunological 
enhancement to prolong graft survival, corticosteroids or 
other immunosuppressive drugs could be avoided. Consequently, 
the observed hypertension could not be due to the effect of 
drugs but must have originated from the allograft. Impairment 
of the GFR itself did not cause a rise in blood pressure as 
was seen in rats with one ischemic kidney and contralateral 
nephrectomy. The presence of one intact native kidney in 
combination with an allograft also resulted in normotensive 
recipients. Removal of the native kidney six weeks after 
transplantation again led to hypertensive allografted 
recipient rats. Marked histopathological changes in the 
allograft together with impairment of the GFR and low plasma 
renin concentrations of the recipient rats led us conclude 
that the observed hypertension in this model is the result of 
immunological alterations in the kidney mediated by sodium 
retention. A better immunosuppressive regimen or a low sodium 
intake appear indicated to circumvent this kind of 
hypertension. 
8.5 ALLOGENEIC KIDNEY TRANSPLANTATION WITH IMMUNOSUPPRESSIVE 
DRUGS (chapters 4 and 5) 
In our opinion, donor strain pretreatment will prolong 
graft survival in the allogeneic transplantation model, 
although it will not entirely prevent rejection. Therefore, 
two different immunosuppressive agents were tested alone or in 
combination with preimmunization with donor strain blood. We 
wanted to know if additional or more effective immuno-
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suppression could circumvent post-transplantation hyper-
tension. The immunosuppressive agents we used were Cyclo-
sporin A and prednisolone. The first drug was chosen because 
no direct effects of Cyclosporin A on the blood pressure had 
been reported at that time. The second drug was chosen because 
corticosteroids are still frequently used in transplanatation 
centers and because these drugs have a potential for raising 
blood pressure. In contrast to the combination of prednisolone 
and donor strain blood pretreatment, Cyclosporin A together 
with blood pretreatment did not show any synergistic effects 
on the survival or the graft function of the recipient rats. 
We believe that this is due to the high dosage of Cyclosporin 
we have used. Such dosage probably outweighs the effects of 
donor strain blood pretreatment on the blood pressure and the 
renal allograft function. In case of prednisolone, synergism 
was noted, albeit only found when prednisolone was given in 
low dose. 
With either Cyclosporin A or low dose prednisolone, no 
elevation of the blood pressure was observed on our allogeneic 
transplantation model. Adequately immunosuppressed recipient 
rats (with either Cyclosporin A as only treatment or with 
prednisolone as adjuvant treatment) do not show any elevation 
in blood pressure after transplantation. This points to an 
important role for rejection in the development of 
hypertension in this model. 
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8.6 ALLOGENEIC KIDNEY TRANSPLANTATION AND SODIUM 
(chapters 6 and 7) 
As mentioned above, sodium retention might be the precursor 
of the observed hypertension in the original allogeneic 
transplanation model. We therefore speculated that a decrease 
in the sodium intake might result in normotensive recipient 
rats. We tested a semi-synthetic sodium-poor diet containing 
less than 15% sodium compared with normal food. On this diet 
recipient rats did remain within the blood pressure range of 
normotensive control rats. The sodium-poor diet had a positive 
effect both on the GFR and the survival of the recipient rats. 
The results from the metabolic studies suggest a different 
handling of water and sodium by the allograft in the first ten 
days after transplantation. An increase in the plasma volume 
of recipient rats after transplantation was also noted. These 
findings all point to the conclusion that sodium is involved 
in the rise in blood pressure in this model. 
Several studies in humans also suggest that 
sodium accumulation in the body is involved in the patho-
genesis of essential hypertension. Studies of the importance 
of body sodium content in post-renal transplantation hyper-
tension have only rarely been carried out. Ducrot and 
coworkers (1961) found no significant changes in exchangeable 
sodium measured before and after renal transplantation in 
recipients with post-transplantation hypertension, whereas 
Swales (1967) found that changes in exchangeable sodium were 
correlated to changes in blood pressure in two recipients 
examined during the first weeks after renal transplantation. 
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In another study (Horvath et al., 1976), a correlation was 
found between changes in extracellular volume during oral 
sodium loading and changes in blood pressure in hypertensive 
and normotensive renal transplant recipients. Finally, in a 
controlled study Kornerup (1977) found a significant rise in 
exchangeable sodium in hypertensive recipients, in contrast 
with an insignificant drop in normotensive recipients before 
and after transplantation. These findings may suggest that 
sodium retention could be involved in the pathogenesis of 
post-renal transplantation hypertension in humans. 
8.7 CONCLUSIONS 
The following conclusions can be drawn from the experiments 
described in the preceding chapters. 
Isogeneic 
the rat 
and allogeneic kidney transplantation models in 
are suitable to study hypertension after 
transplantation. 
The presence of a grafted kidney in the isogeneic 
transplantation model does not cause a rise in blood 
pressure in the recipient rats. 
- In the allogeneic transplantation model, where graft 
survival is prolonged with donor strain blood pretreatment, 
blood pressure starts to rise in the second week after 
transplantation. 
- Chronic rejection of the allograft results in functional 
alterations in the kidney, causing retention of sodium and 
water and leading to a volume-dependant hypertension. 
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The rise in blood pressure can be prevented by either better 
immunosuppression or a reduction in the daily sodium intake. 
8.8 REFERENCES 
APERIA A, HERIN Development of glomerular fltration 
perfusion rate and nephron filtration rate in rats 17-60 days 
old. Am. J. Physiol., 228:1319, 1975. 
BENGELE HH, SOLOMON S. Development of the renal response to 
blood volume expansion in the rat. Am. J. Physiol., 227:364, 
1974. 
BROCHNER-MORTENSEN J, RODBRO P. Selection of routine methods 
for determination of glomerular filtration rate in adult 
patients. Scand. J. Clin. Lab. Invest., 36:35, 1976. 
BRYAN CW, JARCHOW RC, MAHER JF. Measurement of the glomerular 
filtration rate in small animals without urine collection. 
J. Lab. Clin. Med., 80:845, 1972. 
CHANTLER C, GARNETT ES, PARSONS V, VEALL N. 
filtration rate measurement in man by the single 
method using 51 Cr-EDTA. Clin. Sci., 37:169, 1969. 
Glomerular 
injection 
DAHL LK, HEINE M. Primary role of renal homografts in setting 
blood pressure in rats. Circ. Res., 34:94, 1975. 
DITZEL I, VESTERGAARD P, BRINKLOV M. Glomerular filtration 
rate determined by 51 Cr-DTA complex. Scand. J. Urol. 
Nephrol., 6:166, 1972. 
DUCROT H, JUNGERS P, FUNCK-BRENTANO JL, PERRIN D, CROSNIER J, 
HAMBURGER J. La correction de l'hypertension arterielle par la 
transplantation renale chez l'homme. Pathol. Biol., 13:1070, 
1965. 
FREIS ED. Salt, volume and the prevention of hypertension. 
Circulation, 53:589, 1976. 
HORSTER M, LEWY JE. Filtration fraction and extraction of PAH 
during neonatal period in the rat. Am. J. Physiol., 219:1061, 
1970. 
HORVATH JS, BAXTER C, FURBY F, HOOD V, JOHNSON J, McGRATH B, 
TILLER DJ. Plasma renin activity, plasma angiotensin II and 
extracellular fluid volume in patients after renal 
transplantation. Clin. Sci. Mol. Med., 51 suppl.3:227, 1976. 
MARQUET RL. Induction of specific unresponsiveness to organ 
allografts. Thesis, Leiden, 1978. 
112 
KORNERUP HJ. The significance of body sodium content in 
tension following renal transplantation, exchangeable 
and plasma renin concentrations before and after 
transplantation. Scand. J. Lab. Invest., 37:295, 1977. 
hyper-
sodium 
renal 
LAYZELL D, MILLER T. Determination of glomerular filtration 
rate in the rat using 51 Cr-EDTA and a single blood sample. 
Invest. Urol., 13:200,1975. 
McDOUGALL JG, COUGHLAN JP, DENTON 
autotransplants in sheep: investigations 
renovascular hypertension. Clin. Exp. 
8:497, 1981. 
DA et al. Renal 
of renal function and 
Pharmacol. Physiol., 
PROVOOST AP, DE KEIJZER MH, KORT WJ et al. 
the recipient upon renal function after 
transplantation in the rat. Transplantation, 
The influence of 
isogeneic kidney 
37:55, 1984. 
PROVOOST AP, MOLENAAR JC. Changes in the glomerular filtration 
rate after unilateral nephrectomy in rats. Pflugers Arch., 
385:161, 1980. 
SWALES JD. Sodium metabolism in relation to changing 
pressure levels in human renal transplantation. Am. J. 
Sci., 253:531, 1967. 
blood 
Med. 
113 
SUMMARY 
Kidney transplantation has become one of the most 
important therapeutic modalities for terminal renal 
insufficiency. During the past thirty years a great deal of 
research has been carried out concerning, in particular, more 
effective means of protecting the graft against rejection. An 
optimal method has not yet been found and the postoperative 
course of kidney recipients is complicated by incompletely 
treated graft rejection, coupled with the side effects of the 
immunosuppressive drugs administered to counteract that 
rejection. One of these postoperative complications consists 
of a rise in blood pressure. The development of hypertension 
causes diagnostic and therapeutic problems in many cases. This 
dissertation describes methods of inducing and combatting 
hypertension after allogeneic kidney transplantation between 
two inbred rat strains. A hypothesis is developed on the cause 
of this hypertension in the kidney recipient. Finally, this 
hypothesis is experimentally substantiated. 
Chapter 1 gives an overview of the new developments in 
the field of renal transplantation in general and of the 
effects of immunosuppressive drugs in particular. Percentages 
are supplied and discussed regarding the occurrence of hyper-
tension after kidney transplantation in children and adults. 
Finally, the various causative factors for hypertension after 
kidney transplantation as mentioned in the literature, are 
discussed. 
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Chapter 2 deals with the isogeneic renal transplantation 
model. It appears that in this model the recipients remain 
normotensive. It is affect concluded that the transplantation 
procedure as such does not influence the blood pressure of the 
recipient, not even when kidneys are transplanted from adult 
donors into juvenile rats. 
Chapter 3 deals with the allogeneic renal transplantation 
model, whereby the allograft survival is prolonged by means of 
pretreatment with donor strain blood. It appears that the 
allogeneic kidney recipient becomes hypertensive in the second 
week after transplantation. This hypertension is associated 
with a reduction in the glomerular filtration rate (GFR) and a 
suppression of the plasma renin release. It is assumed that a 
partial rejection does occur in spite of the prolonged graft 
survival, causing damage in the allografted kidney, which 
leads to sodium retention and eventually hypertension. 
Chapter 4 describes the effects on blood pressure and 
renal function of an improved method of immunosuppression 
using Cyclosporin A. With Cyclosporine A administration, the 
recipients appear to remain normotensive, while renal function 
is markedly improved. It is assumed that the use of 
Cyclosporine A prevents the partial rejection that does occur 
with donor strain blood pretreatment. The combined use of 
Cyclosporine A and pretreatment with donorstrain blood does 
not lead to an extra improvement of renal function in the 
recipients and/or survival of these rats in comparison with 
recipients that were treated with Cyclosporine A alone. 
Chapter 5 describes the immunosuppressive effect and 
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potential for raising blood pressure of continuous 
prednisolone infusion. This method of immunosuppression 
appears to raise the systolic blood pressure (SBP) and the 
GFR, while it results in a significant loss of body weight. 
These effects appear to be dose-related; prednisolone was 
administered in diverse doses during the first two weeks after 
transplantation. The same effects were found in unilaterally 
nephrectomized control rats. After cessation of the 
prednisolone administration, the recipients remain hyperten-
sive, while the GFR decreases. Pretreatment of the recipients 
with donor strain blood results in a drop in blood pressure to 
normotensive values, after cessation of the prednisolone 
administration. A reduction in the dose of prednisolone for 
the recipients pretreated with donor strain blood, results in 
recipients whose blood pressure remains normotensive 
throughout the study period. A further reduction in the dose 
of prednisolone, once again leads to hypertension. 
In chapter 6, the premise of sodium retention as 
causative factor for post-renal transplantation hypertension 
is investigated by putting the rat kidney recipients on a low-
sodium diet. It appears that these recipients do not become 
hypertensive, while their GFR is significantly higher than the 
GFR of recipients on a standard diet. The survival time for 
rats on a sodium-poor diet is also significantly higher. In 
this chapter, it is also demonstrated that a poor renal 
function as such does not lead to a rise in blood pressure in 
the rat. It is also shown that the presence of a native, 
intact kidney in the recipient will prevent a rise in blood 
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pressure. 
Chapter 7 described the feasibility of a connection 
between the GFR and the SBP of recipients pretreated with 
donor strain blood, amounting to a weak, albeit significant, 
inverse correlation. In addition, a metabolic experiment is 
described, revealing a positive sodium and water balance 
during the first week after transplantation. The recipients 
show proteinuria and calciuria, while the osmolality of the 
urine is markedly reduced. Finally, it appears that the 
recipient rats have a higher plasma volume than unilaterally 
nephrectomized rats, suggesting an enlarged extracellular 
volume of the recipient rats. 
The general discussion highlights the methods applied. It 
appears that the data obtained from the metabolic experiments 
are not conducive to simple explanations regarding the sodium 
and water balance. Finally, a feasible hypothesis is drawn up 
that would explain the post-transplantation 
partial graft rejection causes changes 
hypertension. A 
in the kidney, 
resulting in retention of sodium and water, which leads to a 
rise in blood pressure. 
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SAMENVATTING 
Om terminale nierinsuffici~ntie te behandelen is nier-
transplantatie een van de meest belangrijke behandelingen 
geworden. In de afgelopen dertig jaar is veel onderzoek 
verricht naar met name effectievere manieren om het 
transplantaat tegen afstoting te beschermen. De meest optimale 
methode is echter nog niet gevonden en ontvangers van nieren 
ondervinden problemen door enerzijds een niet optimaal 
behandelde afstotingsreactie en anderzijds door bijwerkingen 
van de toegediende immunosuppressiva. 
in de post-operatieve periode is 
Een van de complicaties 
het ontstaan van een 
verhoogde bloeddruk. In dit proefschrift wordt een methode 
beschreven die na niertransplantatie tussen ratten van twee 
ingeteelde stammen leidt tot een verhoogde bloeddruk bij de 
nierontvangers. Een hypothese is opgesteld om de hypertensie 
te verklaren en wordt daarna getoetst op zijn juistheid. 
In hoofdstuk 1 wordt een overzicht gegeven van de 
ontwikkelingen op het niertransplantatiegebied in het algemeen 
en van de gebruikte immunosuppressieve middelen. Tevens worden 
van kinderen en volwassenen percentages van hypertensieve 
recipienten vermeld en toegelicht. Tenslotte wordt ingegaan op 
de verschillende factoren die in de literatuur genoemd worden 
als mogelijke oorzaak voor hypertensie na niertransplantatie. 
Hoofdstuk 2 beschrijft het isogene transplantatie model. 
Het blijkt dat in dit model de ontvangers normotensief 
blijven. Geconcludeerd kan worden dat de transplantatie 
procedure op zich geen invloed op de bloeddruk heeft, zelfs 
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niet indien er nieren getransplanteerd worden van volwassen 
naar jonge ratten. 
Hoofdstuk 3 behandelt het allogene transplantatie model, 
waarbij de transplantaat overleving verlengd wordt door 
voorbehandeling van de ontvanger met donor bloed. De allogene 
nierrecipienten blijken in de tweede week na transplantatie 
hypertensief te worden. Dit gaat gepaard met een verlaging van 
de glomerulaire filtratie snelheid en een onderdrukking van de 
plasma renine afgifte. Verondersteld wordt dat er ondanks de 
verlengde transplantaat overleving toch een gedeeltelijke 
afstoting plaatsvindt, waardoor veranderingen in de nier 
optreden die aanleiding geven tot natrium retentie en daardoor 
tot hypertensie. 
Hoofdstuk 4 beschrijft daarom de effecten van een 
verbeterde immunosuppressie met behulp van Cyclosporine A op 
de bloeddruk en de nierfunctie. Bij gebruik van Cyclosporine A 
blijken de ontvangers normotensief te blijven, terwijl de 
nierfunctie aanzienlijk verbeterd. Het idee is dat door het 
gebruik van Cyclosporine A de gedeeltelijke afstoting, die wel 
plaats vindt na voorbehandeling met donorbloed, achterwege 
blijft. Het gebruik van Cyclosporine A plus voorbehandeling 
met donorbloed geeft geen extra verbetering in nierfunctie 
en/of overleving van de aldus behandelde nierontvangers in 
vergelijking met nierontvangers die met Cyclosporine A alleen 
behandeld werden. 
In hoofdstuk 5 worden de immunosuppressieve en hyper-
tensiogene effecten beschreven van een continu prednisolone 
infuus. Prednisolone wordt in verschillende doses gedurende de 
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eerste twee weken na transplantatie toegediend. Dit blijkt de 
systolische bloeddruk en de glomerulaire filtratie snelheid te 
verhogen. Tevens vindt er een aanzienlijke afname van het 
lichaamsgewicht plaa~s- Deze effecten zijn dosis afhankelijk 
en komen ook voor bij de eenzijdig genefrectomeerde controle 
ratten. Na stopzetting van de prednisolone toediening blijven 
de nierontvangers hypertensief, terwijl de glomerulaire 
filtratie snelheid daalt. Voorbehandeling van de ontvangers 
met donorbloed resulteert na het stoppen van de prednisolone 
toediening in een daling van de bloeddruk tot normotensieve 
waarden. Verlaging van de prednisolone dosis in de met 
donorbloed voorbehandelde ratten leidt tot ontvangers die 
gedurende het onderzoek een normotensieve bloeddruk houden. 
Een verdere verlaging van de prednisolone dosis geeft weer 
aanleiding tot hypertensie. 
In hoofdstuk 6 wordt de eerder veronderstelde natrium 
retentie nader onderzocht door de met donorbloed 
voorbehandelde ontvangers een laag zout dieet aan te bieden. 
Het blijkt dat deze ratten niet hypertensief worden, terwijl 
de· glomerulaire filtratie snelheid aanmerkelijk hoger is dan 
die van ontvangers op standaard dieet. Ook de overleving van 
de ratten op het laag zout dieet is beter. In dit hoofdstuk 
wordt ook aangetoond dat bij ratten een slechte nierfunctie op 
zich geen aanleiding geeft tot een verhoogde bloeddruk. Tevens 
wordt aangetoond dat de aanwezigheid van een intacte eigen 
nier naast de getransplanteerde nier de stijging van de 
bloeddruk voorkomt. 
In hoofdstuk 7 wordt een mogelijk verband beschreven tussen 
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de glomerulaire filtratie snelheid en de systolische bloeddruk 
van ontvangers die voorbehandeld waren met donorbloed. Er 
wordt een zwak significante, lineaire en omgekeerde correlatie 
aangetoond. Tevens wordt in een metaboolexperiment aangetoond 
dat er gedurende de eerste week na transplantatie sprake is 
van een positieve natrium- en waterbalans. De ontvangers 
vertonen proteinurie en calciurie, terwijl de osmolaliteit van 
de urine na transplantatie aanzienlijk verlaagd is. Tens lotte 
blijkt dat het plasma volume van de recipient ratten hoger is 
dan dat van eenzijdig genefrectomeerde ratten, reden om te 
veronderstellen dat het extracellulair volume van de recipient 
ratten vergroot is. 
In de discussie wordt ingegaan op de gebruikte methodieken 
en wordt onder meer geconcludeerd dat uit de gegevens 
verkregen uit de metaboolexperimenten een natrium- en water 
balans moeilijk op te maken is. Als conclusie van dit 
onderzoek wordt een hypothese opgesteld om de hypertensie te 
verklaren. Door een gedeeltelijke afstoting van het 
transplantaat vinden in de nier veranderingen plaats die 
aanleiding geven tot retentie van natrium en water, waardoor 
een verhoging van de bloeddruk plaatsvindt. 
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